<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus - Bennett, C - 2020 | Cochrane Library</title> <meta content="Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus - Bennett, C - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007334.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus - Bennett, C - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007334.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007334.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus" name="citation_title"/> <meta content="Cathy Bennett" name="citation_author"/> <meta content="Coventry University" name="citation_author_institution"/> <meta content="Susi Green" name="citation_author"/> <meta content="Portsmouth Hospitals Trust" name="citation_author_institution"/> <meta content="John DeCaestecker" name="citation_author"/> <meta content="University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Max Almond" name="citation_author"/> <meta content="Gloucestershire Royal Hospital" name="citation_author_institution"/> <meta content="Hugh Barr" name="citation_author"/> <meta content="Gloucester Royal Hospital" name="citation_author_institution"/> <meta content="Pradeep Bhandari" name="citation_author"/> <meta content="Portsmouth Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Krish Ragunath" name="citation_author"/> <meta content="Queens Medical Centre, Nottingham University NHS Trust" name="citation_author_institution"/> <meta content="Rajvinder Singh" name="citation_author"/> <meta content="The Lyell McEwin Hospital" name="citation_author_institution"/> <meta content="Janusz Jankowski" name="citation_author"/> <meta content="Blizard Institute" name="citation_author_institution"/> <meta content="janusz.jankowski@uhcw.nhs.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD007334.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/05/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007334.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007334.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007334.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Barrett Esophagus [pathology, *surgery]; Esophageal Neoplasms [pathology, *surgery]; Esophagoscopy [*methods]; Precancerous Conditions [pathology, *surgery]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007334.pub5&amp;doi=10.1002/14651858.CD007334.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="PrHmaMrX";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007334\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007334\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","hr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007334.pub5",title:"Surgery versus radical endotherapies for early cancer and high\\u2010grade dysplasia in Barrett\u0027s oesophagus",firstPublishedDate:"May 22, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PrHmaMrX&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007334.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007334.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007334.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007334.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007334.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007334.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007334.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007334.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007334.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007334.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2338 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007334.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0055"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-sec-0045"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/appendices#CD007334-sec-0059"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Surgery versus radical endotherapies for early cancer and high‐grade dysplasia in Barrett's oesophagus </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0004">Cathy Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0005">Susi Green</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0006">John DeCaestecker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0007">Max Almond</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0008">Hugh Barr</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0009">Pradeep Bhandari</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0010">Krish Ragunath</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0011">Rajvinder Singh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information#CD007334-cr-0012"><i class="icon corresponding-author fa fa-envelope"></i>Janusz Jankowski</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information/en#CD007334-sec-0085">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 May 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007334.pub5">https://doi.org/10.1002/14651858.CD007334.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007334-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007334-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007334-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007334-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007334-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007334-abs-0001" lang="en"> <section id="CD007334-sec-0001"> <h3 class="title" id="CD007334-sec-0001">Background</h3> <p>Barrett's oesophagus is one of the most common pre‐malignant lesions in the world. Currently the mainstay of therapy is surgical management of advanced cancer but this has improved the five‐year survival very little since the 1980s. As a consequence, improved survival relies on early detection through endoscopic surveillance programmes. Success of this strategy relies on the fact that late‐stage pre‐malignant lesions or very early cancers can be cured by intervention. Currently there is considerable controversy over which method is best: that is conventional open surgery or endotherapy (techniques involving endoscopy). </p> </section> <section id="CD007334-sec-0002"> <h3 class="title" id="CD007334-sec-0002">Objectives</h3> <p>We used data from randomised controlled trials (RCTs) to examine the effectiveness of endotherapies compared with surgery in people with Barrett's oesophagus, those with early neoplasias (defined as high‐grade dysplasia (HGD) and those with early cancer (defined as carcinoma in‐situ, superficially invasive, early cancer or superficial cancer T‐1m (T1‐a) and T‐1sm (T1‐b)). </p> </section> <section id="CD007334-sec-0003"> <h3 class="title" id="CD007334-sec-0003">Search methods</h3> <p>We used the Cochrane highly sensitive search strategy to identify RCTs in MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), ISI Web of Science, EBMR, Controlled Trials mRCT and ISRCTN, and LILACS, in July and August 2008. The searches were updated in 2009 and again in April 2012. </p> </section> <section id="CD007334-sec-0004"> <h3 class="title" id="CD007334-sec-0004">Selection criteria</h3> <p>Types of studies: RCTs comparing endotherapies with surgery in the treatment of high‐grade dysplasia or early cancer. All cellular types of cancer were included (i.e. adenocarcinomas, squamous cell carcinomas and more unusual types) but will be discussed separately. </p> <p>Types of participants: patients of any age and either gender with a histologically confirmed diagnosis of early neoplasia (HGD and early cancer) in Barrett's or squamous lined oesophagus. </p> <p>Types of interventions; endotherapies (the intervention) compared with surgery (the control), all with curative intent. </p> </section> <section id="CD007334-sec-0005"> <h3 class="title" id="CD007334-sec-0005">Data collection and analysis</h3> <p>Reports of studies that meet the inclusion criteria for this review would have been analysed using the methods detailed in <a href="http://Appendix 9" target="_blank">Appendix 9</a>. </p> </section> <section id="CD007334-sec-0006"> <h3 class="title" id="CD007334-sec-0006">Main results</h3> <p>We did not identify any studies that met the inclusion criteria. In total we excluded 13 studies that were not RCTs but that compared surgery and endotherapies. </p> </section> <section id="CD007334-sec-0007"> <h3 class="title" id="CD007334-sec-0007">Authors' conclusions</h3> <p>This Cochrane review has indicated that there are no RCTs to compare management options in this vital area, therefore trials should be undertaken as a matter of urgency. The problems with such randomised methods are standardising surgery and endotherapies in all sites, standardising histopathology in all centres, assessing which patients are fit or unfit for surgery and making sure there are relevant outcomes for the study (i.e. long‐term survival (over five or more years)) and no progression of HGD. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007334-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007334-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007334-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007334-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007334-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007334-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007334-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007334-abs-0002" lang="en"> <h3>Surgery versus endoscopic therapies for early oesophageal cancer in Barrett's oesophagus</h3> <p>This Cochrane review has indicated that there are no randomised controlled trials to compare management options in this vital area, therefore trials should be undertaken as a matter of urgency. Current use of endotherapies in the care of patients with early cancer or high‐grade dysplasia of Barrett's oesophagus should be at the recommendation of the multi‐disciplinary team involved in individual care. Properly conducted randomised controlled trials comparing surgery with endotherapies should be conducted before any conclusions can be drawn. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007334-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007334-sec-0055"></div> <h3 class="title" id="CD007334-sec-0056">Implications for practice</h3> <section id="CD007334-sec-0056"> <p>No data were available to permit an analysis of the relative benefits or harms of endotherapies compared with surgery (oesophagectomy). Current use of endotherapies in the care of patients with early cancer or HGD of Barrett's oesophagus should be at the recommendation of the multi‐disciplinary team involved in individual patient care. Properly conducted, RCTs comparing surgery with endotherapies should be carried out before any conclusions can be drawn. </p> </section> <h3 class="title" id="CD007334-sec-0057">Implications for research</h3> <section id="CD007334-sec-0057"> <p>Collaborative work between patients who make informed decisions to participate in RCTs, carers, clinicians and researchers in order to produce large clinically relevant data is paramount, to ensure outcomes are relevant and participation is maximised. Future RCTs, comparing oesophagectomy with endotherapies are required. Attention should be paid to: </p> <p> <ul id="CD007334-list-0004"> <li> <p>collection of detailed demographic/baseline data, fitness for surgery, histologically confirmed stage of cancer or HGD of oesophagus (good internal validity); </p> </li> <li> <p>employing randomised allocation to treatment groups;</p> </li> <li> <p>a comparison of surgery versus endotherapies in comparable participant groups;</p> </li> <li> <p>adequate power (employing perhaps a multicentre design);</p> </li> <li> <p>relevant outcomes, including long‐term follow‐up, adverse effects (researchers should also collect and report reasons for drop‐out); reporting long‐term outcomes compared in an RCT for surgery versus endotherapies for treatment of oesophageal HGD. These data would add to the evidence base to assist in the planning and implementation of cancer care services by healthcare providers; </p> </li> <li> <p>cost analyses; and</p> </li> <li> <p>endoscopic and surgical interventions standardised throughout sites (internal validity).</p> </li> </ul> </p> <p>The results of such studies should be incorporated into evidence‐based practice guidelines.</p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007334-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007334-sec-0008"></div> <section id="CD007334-sec-0009"> <h3 class="title" id="CD007334-sec-0009">Description of the condition</h3> <p>Barrett's oesophagus is an acquired condition resulting from persistent and severe mucosal injury to the oesophagus. It develops as a result of chronic reflux of duodenogastric contents (<a href="./references#CD007334-bbs2-0031" title="CaldwellMT , LawlorP , ByrnePJ , WalshTN , HennessyTP . Ambulatory oesophageal bile reflux monitoring in Barretts oesophagus. British Journal of Surgery1995;82:657-60.">Caldwell 1995</a>; <a href="./references#CD007334-bbs2-0114" title="VaeziMF , RichterJE . Synergism of acid and duodenogastroesophageal reflux in complicated Barrett oesophagus. Surgery1995;117:699-704.">Vaezi 1995</a>). Exposure to acid, bile and other constituents of refluxate causes cellular and deoxyribonucleic acid (DNA) damage as well as altering the differentiation of proliferating cells. The normal squamous epithelium of the distal oesophagus is replaced with the columnar type of epithelium normally found in gastric cardia, the gastric fundus and the upper intestine resulting in a macroscopically visible change, obvious through a normal endoscope. The British Society of Gastroenterology guidelines define Barrett's oesophagus as "an endoscopically apparent area above the gastro‐oesophageal junction that is suggestive of Barrett's which is supported by the findings of columnar lined oesophagus on histology" (<a href="./references#CD007334-bbs2-0089" title="PlayfordRJ . New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut2006;55:442-3.">Playford 2006</a>). </p> <p>Barrett's is asymptomatic and common, being detected in 0.5% of post‐mortem studies (<a href="./references#CD007334-bbs2-0032" title="CameronAJ , ZinsmeisterAR , BallardDJ , CarneyJA . Prevalence of columnar-lined (Barrett's) oesophagus. Comparison of population based clinical and autopsy findings. Gastroenterology1990;99(4):918-22.">Cameron 1990</a>), 15% to 20% of those undergoing upper gastrointestinal endoscopy for symptoms of chronic gastro‐oesophageal reflux (<a href="./references#CD007334-bbs2-0119" title="WintersC , SpurlingTJ , ChobanianSJ , CurtisDJ , EspositoRL , CotelingamJD , et al. Barrett's esophagus. A prevalent occult complication of gastroesophageal reflux disease. Gastroenterology1987;92:118-24.">Winters 1987</a>) and 1.6% of the general Swedish population (<a href="./references#CD007334-bbs2-0094" title="RonikainenJ , AroP , StorskrubbT , JohanssonS , LindT , Bolling-SternevoldE , et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology2005;129:1825-31.">Ronkainen 2005</a>). The major concern is the potential of progression to malignancy. The cancers that occur in areas of Barrett's oesophagus are almost exclusively adenocarcinomas (<a href="./references#CD007334-bbs2-0030" title="ByrneJP , MathersJM , ParryJM , AttwoodSEA , BancewiczJ , WoodmanCBJ . Site distribution of oesophageal cancer. Journal of Clinical Pathology2002;55:191-4.">Byrne 2002</a>). </p> <p>It is thought that adenocarcinoma in Barrett's epithelium does not arise as a single event but rather follows a stepwise process from metaplasia through low‐grade (LGD) and high‐grade dysplasia (HGD) to early carcinoma and eventually to invasive cancer (<a href="./references#CD007334-bbs2-0064" title="JankowskiJA , WrightNA , MeltzerSJ , TriadafilopoulosG , GeboesK , CassonAG , et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the oesophagus. American Journal of Pathology1995;154:965-73.">Jankowski 1995</a>). Progression from non‐dysplastic Barrett's oesophagus to malignancy is rare but a diagnosis of dysplasia within Barrett's section confers an increased risk, most significant with HGD (<a href="./references#CD007334-bbs2-0029" title="ButtarNS , WangKK , SeboTJ , RiehleDM , KrishnadathKK , LutzkeLS , et al. Extent of high grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology2001;120:1630-9.">Buttar 2001</a>; <a href="./references#CD007334-bbs2-0091" title="ReidBJ , LevineDS , LongtonG , BlountPL , RabinovitchPS . Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. American Journal of Gastroenterology2000;95(7):1669-76.">Reid 2000</a>). </p> <p>Every year in the UK around 7000 cases of oesophageal cancer are diagnosed. The vast majority of these (&gt; 85%) are either adenocarcinomas (<a href="./references#CD007334-bbs2-0030" title="ByrneJP , MathersJM , ParryJM , AttwoodSEA , BancewiczJ , WoodmanCBJ . Site distribution of oesophageal cancer. Journal of Clinical Pathology2002;55:191-4.">Byrne 2002</a>) or squamous cell carcinomas. Worldwide, the incidence rate of squamous cell carcinoma of the oesophagus is fairly stable, but there is an increasing trend of incidence for oesophageal adenocarcinomas in some European countries and the US (<a href="./references#CD007334-bbs2-0116" title="VizcainoAP , MorenoV , LambertR , ParkinDM . Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. International Journal of Cancer2002;99(6):860-8.">Vizcaino 2002</a>). In the UK and US (in white men), adenocarcinoma is now the dominant histology (<a href="./references#CD007334-bbs2-0038" title=" Cancer Research UK . UK Oesophageal cancer incidence statistics. info.cancerresearchuk.org/cancerstats/types/oesophagus/incidence/uk-oesophageal-cancer-incidence-statistics#Anatomy (accessed 17 May 2012).">CRUK 2012</a>). </p> <p>These two histological types differ in their risk factors and pathobiology. Adenocarcinomas tend to develop in white males with centripetal obesity and Barrett's oesophagus (<a href="./references#CD007334-bbs2-0037" title="CorleyDA , KuboA , LevinTR , BlockG , HabelL , ZhaoW , et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology2007;133:34-41.">Corley 2007</a>; <a href="./references#CD007334-bbs2-0043" title="EdelsteinZR , FarrowDC , BronnerMP , RosenSN , VaughanTL . Central adiposity and risk of Barrett's esophagus. Gastroenterology2007;133(2):403-11.">Edelstein 2007</a>; <a href="./references#CD007334-bbs2-0052" title="HampelH , AbrahamNS , El-SeragHB . Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Annals of Internal Medicine2005;143(3):199-211.">Hampel 2005</a>). Squamous cell carcinomas are more strongly associated with smoking (<a href="./references#CD007334-bbs2-0035" title="ChenZM , XuZ , CollinsR , Li W-X, PetoR . Early health effects of the emerging tobacco epidemic in China: a 16-year prospective study. Journal of the American Medical Association1997;278:1500-4.">Chen 1997</a>), alcohol (<a href="./references#CD007334-bbs2-0112" title="ThunMJ , PetoR , LopezAD , MonacoJH , HenleySJ , Heath CW Jr, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. New England Journal of Medicine1997;337:1705.">Thun 1997</a>), and diets rich in salted meat, salted fish, pickled vegetables and lacking in fresh fruit, fresh vegetables and vitamins A and C (<a href="./references#CD007334-bbs2-0028" title="BrownLM , SwansonCA , GridleyG , SwansonGM , SilvermanDT , GreenbergRS , et al. Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Causes and Control1998;9(5):467-74.">Brown 1998</a>; <a href="./references#CD007334-bbs2-0059" title="HungHC , HuangMC , LeeJM , WuDC , HsuHK , WuMT . Association between diet and esophageal cancer in Taiwan. Journal of Gastroenterology and Hepatology2004;19(6):632-7.">Hung 2004</a>). Variations in alcohol metabolism may contribute to the risk of developing squamous cell cancers (<a href="./references#CD007334-bbs2-0046" title="EngelLS , ChowWH , VaughanTL , GammonMD , RischHA , StanfordLM , et al. Population attributable risks of esophageal and gastric cancers. Journal of the National Cancer Institute2003;95:1404.">Engel 2003</a>; <a href="./references#CD007334-bbs2-0078" title="MoritaM , KuwanoH , OhnoS , SugimachiK , SeoY , TomodaH , et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. International Journal of Cancer1994;58:207-10.">Morita 1994</a>). <a href="./references#CD007334-bbs2-0033" title="ChakA , LeeT , KinnardM , BrockW , FaulxA , WillisJ , et al. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut2002;51(3):323-8.">Chak 2002</a> demonstrated in a small case control study that individuals with Barrett's oesophagus and adenocarcinoma had a positive family history of these disorders more frequently than control cases who did not have a family history of these conditions. There is probably a genetic susceptibility to gastro‐oesophageal reflux disease (GORD) (<a href="./references#CD007334-bbs2-0040" title="de Vries DR, ter Linde JJM, van Herwaarden MA, Smout AJPM, Samsom M. Gastroesophageal reflux disease is associated with the C825T polymorphism in the g-protein 3 subunit gene (GNB3). American Journal of Gastroenterology2009;104:281-5.">de Vries 2009</a>) and this may be a component in the development of Barrett's oesophagus and oesophageal cancer (<a href="./references#CD007334-bbs2-0069" title="LagergrenJ , BergströmR , LindgrenA , NyrénO . Symptomatic gastroesophageal reflux is a strong risk factor for esophageal adenocarcinoma. New England Journal of Medicine1999;340:825-31.">Lagergren 1999</a>; <a href="./references#CD007334-bbs2-0070" title="LagergrenJ , YeW , LindgrenA , NyrénO . Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers and Prevention2000;9:757-60.">Lagergren 2000</a>; <a href="./references#CD007334-bbs2-0093" title="RomeroY , CameronA , ScaidD , McDonnellS , BurgartL , HardtkeC , et al. Barrett's esophagus: prevalence in symptomatic relatives. American Journal of Gastroenterology2002;97(5):1127-32.">Romero 2002</a>). </p> <p>Both types of cancer can present with a non‐specific early symptomatology, and are often detected late, leading to a poor prognosis (<a href="./references#CD007334-bbs2-0050" title="GreenS , BhandariP , DeCaesteckerJ , BarrH , RagunathK , JankowskiJ , et al. Endoscopic therapies for the prevention and treatment of early esophageal neoplasia. Expert Review of Gastroenterology and Hepatology2011;5(6):731-43. [PMID: 22017700]">Green 2011</a>). An incidence of 12 per 100,000 and a five‐year survival rate of 9% together make oesophageal cancer the third most common cause of cancer death (<a href="./references#CD007334-bbs2-0053" title="HellierMD , SandersonJD , MorrisAI , EliasE , De CaesteckerJ . Care of patients with gastrointestinal disorders in the United Kingdom: a strategy for the future, 2006. www.bsg.org.uk/pdf_word_docs/strategy06_final.pdf. http://(accessed 8 October 2012).">Hellier 2006</a>). Endoscopic developments have enabled diagnosis of these lesions at progressively earlier stages but there is currently no clear guidance for optimal management of early disease such as HGD or mucosal/submucosal cancer with no metastases (T1m/sm N0 M0) once detected. </p> </section> <section id="CD007334-sec-0010"> <h3 class="title" id="CD007334-sec-0010">Description of the intervention</h3> <section id="CD007334-sec-0011"> <h4 class="title">Description of the interventions and how the interventions are thought to work</h4> <section id="CD007334-sec-0012"> <h5 class="title">Surgery</h5> <p>For many years, open total oesophagectomy has been the treatment of choice for early tumours. There are three common techniques ‐ transhiatal, Ivor‐Lewis trans‐thoracic and three stage (McKeown) with or without neo‐adjuvant chemotherapy and/or radiotherapy. No one technique has shown overall superiority and the method selected will depend on the tumour and the preference/experience of the surgeon. All carry a degree of risk in terms of morbidity (<a href="./references#CD007334-bbs2-0055" title="HolscherAH , BollschweilerE , SchneiderPM , SiewertJR . Early adenocarcinoma in Barrett's oesophagus. British Journal of Surgery1997;84:1470-3.">Holscher 1997</a>; <a href="./references#CD007334-bbs2-0111" title="ThomasP , DoddoliC , NevilleP , PonsJ , LienneP , GiudicelliR , et al. Esophageal cancer resection in the elderly. European Journal of Cardiothoracic Surgery1996;11:941-6.">Thomas 1996</a>) and mortality. A range of post‐surgery mortality rates is reported from up to 20% post‐operatively and 85% at five years (<a href="./references#CD007334-bbs2-0113" title="UrbaSG , OrringerMB , TurrisiA , LannettoniM , ForastiereA , StrawdermanM . Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. Journal of Clinical Oncology2001;19:305–13.">Urba 2001</a>), to as low as 2% (<a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a>); 4% (<a href="./references#CD007334-bbs2-0058" title="HulscherF , vanSandickJ , deBoerA , WijnhovenB , TijssenJ , FockensP . Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine2002;347:1662-9.">Hulscher 2002</a>) and 4.9% (at 30 days) (<a href="./references#CD007334-bbs2-0063" title="JamiesonG , MathewG , LudemannR , WaymanJ , MyersJ , DevittP . Postoperative mortality following oesophagectomy and problems in reporting its rate. British Journal of Surgery2004;5:943-7.">Jamieson 2004</a>); results are improved at high‐volume centres using careful case selection (<a href="./references#CD007334-bbs2-0024" title="BirkmeyerJD , SiewersAE , FinlaysonEV , StukelTA , LucasFL , WennbergDE , et al. Hospital volume and surgical mortality in the United States. New England Journal of Medicine2002;346(15):1128-37.">Birkmeyer 2002</a>; <a href="./references#CD007334-bbs2-0034" title="ChangAC , BurkmeyerJD . The volume-performance relationship in esophagectomy. Thoracic Surgery Clinics2006;16:87-91.">Chang 2006</a>; <a href="./references#CD007334-bbs2-0095" title="RouvelasI , JiaC , ViklundP , LindbladM , LagergrenJ . Surgeon volume and postoperative mortality after oesophagectomy for cancer. European Journal of Surgical Oncology2007;33(2):162-8.">Rouvelas 2007</a>; <a href="./references#CD007334-bbs2-0118" title="WhooleyBP , LawS , MurthySC , AlexandrouA , WongJ . Analysis of reduced death and complication rates after esophageal resection. Annals of Surgery2001;233(3):338-44.">Whooley 2001</a>). The third annual report of the UK national oesophago‐gastric audit, which included an estimated 84% of all operations for upper gastrointestinal in England and Wales in 2010, reported an overall inpatient mortality of 4.5% (90‐day mortality 5.7%) following oesophagectomy with curative intent. About 29.8% of patients suffered one or more complications with 8.3% suffering from anastomotic leak. The rate of re‐operation was 10.2% (<a href="./references#CD007334-bbs2-0080" title="The NHS Information Centre. The third annual report of the national oesophago-gastric audit, 2010. www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/NHS%20IC%20OGC%20Audit%202010%20interactive.pdf. (accessed 8 October 2012).">National Oesophago‐gastric Audit 2010</a>). There is some evidence that oesophagectomy performed for HGD or intramucosal cancer (IMC) is associated with a slightly lower morbidity and mortality as patients with early disease tend to be younger with fewer co‐morbidities. </p> <p>New surgical techniques, such as jejunal interposition (<a href="./references#CD007334-bbs2-0110" title="SteinHJ , HutterJ , FeithM , vonRahdenBH . Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Seminars in Thoracic and Cardiovascular Surgery2007;19(1):72-8.">Stein 2007</a>) and minimally invasive laparoscopic and thoracoscopic techniques, have been developed, in addition to other less radical surgical interventions including limited lymphadenectomy and vagal sparing oesophagectomy (<a href="./references#CD007334-bbs2-0015" title="AkiyamaH , TsurumaruM , KawamuraT , OnoY . Esophageal stripping with preservation of the vagus nerve. International Surgery1982;2:125-8.">Akiyama 1982</a>; <a href="./references#CD007334-bbs2-0019" title="BankiF , MasonRJ , HagenJA , BalajiNS , CrookesPF , BremnerCG , et al. Vagal-sparing esophagectomy: a more physiologic alternative. Annals of Surgery2002;236(3):324-36.">Banki 2002</a>). The latter techniques may represent an appropriate alternative to traditional surgery or radical endotherapy for patients with early neoplastic disease (HGD, IMC) and have demonstrated low morbidity and mortality in tertiary centres (<a href="./references#CD007334-bbs2-0041" title="DeMeesterSR . New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal spearing esophagectomy. Annals of Thoracic Surgery2008;85:S747-90.">DeMeester 2008</a>; <a href="./references#CD007334-bbs2-0088" title="PyerC , De MeesterS , RizzettoC , BansalN , TangA , AyaziS , et al. Vagal sparing esophagectomy. The ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Annals of Surgery2007;246(4):665-74.">Peyre 2007</a>). Many clinicians choose to avoid surgery and instead manage selected patients with surveillance alone or with one of several endoscopic therapies to resect or ablate the tumour. </p> </section> <section id="CD007334-sec-0013"> <h5 class="title">Endoscopic treatments</h5> <section id="CD007334-sec-0014"> <h6 class="title">Ablation therapies</h6> <p>Ablation therapies aim to destroy the affected tissue, allowing replacement with normal squamous tissue (<a href="./references#CD007334-bbs2-0097" title="SamplinerR , FennertyMB , GarewalH . Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation. Gastrointestinal Endoscopy1996;44:523-5.">Sampliner 1996</a>). </p> <p>Methods include:</p> <p> <ul id="CD007334-list-0001"> <li> <p>argon plasma coagulation (APC), which uses ionised argon gas to conduct a monopolar current to the tissue, thereby causing necrosis through electrocoagulation. Different depths of necrosis can be achieved by varying the power of the generator, the distance of the probe from the tissue, the amount of gas flow and the duration of application; </p> </li> <li> <p>multipolar electrocautery (MPEC), in which the targeted tissue completes an electrical circuit between two electrodes on the probe tip, thereby causing thermal necrosis; </p> </li> <li> <p>laser therapy, which can be used at various wavelengths to destroy cells at different depths; </p> </li> <li> <p>cryotherapy, which involves the application of extreme cold to destroy the target cells; </p> </li> <li> <p>radiofrequency ablation (RFA) is a relatively recent development. The Barrx system delivers thermal energy through radiofrequency electrodes either through a focal device or coiled around a balloon that inflates to come in contact with the oesophageal wall; and </p> </li> <li> <p>photodynamic therapy (PDT) uses a phototoxic reaction to induce cell death. A photosensitising agent is administered that is absorbed into normal and abnormal cells but retained for a longer period in the abnormal cells. After a suitable time period, an endoscopy is performed to expose the oesophagus to light of an appropriate wavelength. The Barrett's and cancerous cells that have retained the photosensitiser then undergo a delayed cell death. </p> </li> </ul> </p> <p>National Institute for Health and Clinical Evidence (NICE) guidance (UK) currently recommends the use of RFA or PDT in the treatment of flat HGD, combined where appropriate with endoscopic resection (ER) (see below) but it does not prioritise one therapy over another. The use of APC, laser ablation or MPEC alone are not recommended unless as part of a clinical trial but these ablative techniques may be combined with ER (<a href="./references#CD007334-bbs2-0081" title="National Institute for Health and Clinical Excellence. Barrett's oesophagus: ablative therapy for the treatment of Barrett's oesophagus, 2010. www.nice.org.uk/guidance/CG106 (accessed 8 October 2012).">NICE 2010</a>). </p> </section> <section id="CD007334-sec-0015"> <h6 class="title">Endoscopic resection</h6> <p>ER encompasses a range of endoscopic techniques to remove the mucosal and submucosal layers (down to the muscularis propria) of the oesophagus. The conventional technique involves either a simple snare, or a double channel gastroscope with grasping forceps down one of the channels and a snare down the other (strip biopsy technique). Techniques involve suction of the lesion into a plastic cap with or without submucosal injection, using a cap and snare technique or a ligation device. </p> <p>Endoscopic submucosal dissection (ESD) uses a variety of endoscopic knives to dissect out lesions. If the lesion is larger than 2 cm then conventional endoscopic mucosal resection (EMR) techniques will result in multi‐piece resection. Multi‐piece resection can prevent the pathologist from accurately staging the tumour and could lead to a higher rate of local recurrence. The goal and a primary principle of surgical oncology is to remove all of the tumour in one piece and demonstrate that the resected tumour has margins of cancer‐free tissue. In the case of larger lesions, ESD meets this oncological principle, permitting en‐bloc resection of lesions of any size in one piece and avoiding the problems associated with multi‐piece resection. </p> </section> </section> </section> </section> <section id="CD007334-sec-0016"> <h3 class="title" id="CD007334-sec-0016">Why it is important to do this review</h3> <p>The occurrence of HGD and early mucosal cancer in Barrett's oesophagus is an important watershed in the progression of carcinogenesis. Eradication of HGD and early mucosal cancer leads to a very high cure rate whereas missing the consequential invasive cancer leads to an unacceptable progression to incurable disease. In addition, there are several new technologies that have been specifically shown to deal with this condition. </p> <p>The risk of invasive oesophageal adenocarcinoma (invasion into or beyond the submucosa) in patients with biopsy‐detected HGD has formerly been over‐estimated. The majority of cancers detected in this group are T1 cancers and so potentially amenable to endoscopic treatment. The widespread use of ER has dramatically improved disease staging in patients with early lesions and one + </p> <p>meta‐analysis concluded that the incidence of submucosally invasive cancer is only 12.7% in patients with visible HGD in Barrett's and 3% if the HGD does not produce a visible abnormality (<a href="./references#CD007334-bbs2-0067" title="KondaVJ , RossAS , FergusonMK , HartJA , LinS , NaylorK , et al. Is the risk of concomitant invasive esophageal cancer in high grade dysplasia in Barrett's esophagus overestimated?Clinical and Experimental Pathology2008;6(2):159-64.">Konda 2008</a>). In addition, rates of lymphatic metastases appear to be low or absent in T1m (and possibly T1sm1) cancers demonstrating potential for curative endotherapy in these patients without the need for surgical lymphadenectomy (<a href="./references#CD007334-bbs2-0016" title="Alvarez HerreroL , PouwRE , vanVilsterenFG , ten KateFJW , VisserM , van Berge Henegouwen, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy2010;42(12):1030-6.">Alvarez Herrero 2010</a>; <a href="./references#CD007334-bbs2-0073" title="LuiL , HofstetterW , RashidA , SwisherS , CorreaA , AjaniJ , et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. American Journal of Surgical Pathology2005;29:1079-85.">Lui 2005</a>). Improvements in endoscopic imaging are also increasingly enabling diagnosis of oesophageal neoplasia at an earlier, potentially curative, stage. </p> <p>Increasingly clinicians are choosing to avoid surgery as first‐line therapy and instead manage selected patients with endoscopic therapy to resect and ablate the tumour. Surgery is now often reserved as a second‐line intervention following failure of endoscopic therapy, particularly in patients with focal flat HGD; however, this strategy is not fully evidence based. </p> <p>It is vital that clear guidance is available on the optimal treatment of early Barrett's neoplasia. Currently its management remains controversial and clinical practice varies significantly both nationally and internationally. </p> <p>The morbidity and mortality of endoscopic therapies is probably considerably less than surgery. It seems likely (but unconfirmed) that complete ablation of the Barrett's segment, in addition to removal of the early cancer/dysplastic area, may be necessary to prevent the development of metachronous lesions. The long‐term outcomes of these relatively recent developments are becoming clearer, with five‐year survival in one large single centre study being similar to that of an age‐ and country‐matched population (<a href="./references#CD007334-bbs2-0085" title="PechO , BehrensA , MayA , NachbarL , GossnerL , RabensteinT , et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut2008;57:1200-6.">Pech 2008</a>). The lack of any cohesive policy is emphasised by a report suggesting that patients with HGD or IMC within Barrett's are far more likely (86% versus 12%) to undergo oesophagectomy if first seen by a surgeon rather than a gastroenterologist (<a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007334-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007334-sec-0017"></div> <p>The objective of this review was to use data from randomised controlled trials (RCTs) to examine the effectiveness of endotherapies (the intervention) compared with surgery (the control), in two groups of people with Barrett's oesophagus; those with early neoplasias (defined as HGD, and those with early cancer (defined as carcinoma in‐situ, superficially invasive, early cancer or superficial cancer T‐1m (T1‐a) and T‐1sm (T1‐b)). </p> <p>To investigate the following:</p> <p>1) In patients with either HGD or early cancer, who received either endotherapies or surgery, what are the overall survival rates at one, five or more years? </p> <p>We are interested in progression of existing disease, that is, for people who have HGD, the effect of the therapies on rates of progression to cancer and for people having early cancer, progression to more invasive cancer, defined as cancer having greater depth of invasion into the surrounding tissues or spread to distant sites. We have examined the effects of the therapies on both progression and cancer‐free survival as follows: </p> <p>2a) In patients with HGD, are endoscopic therapies effective in terms of reducing rates of progression to cancer? </p> <p>2b) In patients with early cancer, do endoscopic therapies have an effect on rates of progression to more invasive cancer? </p> <p>2c) Are there any differences in the rates of cancer‐free survival for participants with either HGD or early cancer who received endotherapies compared with trial participants who received surgery? </p> <p>In both groups of patients (either HGD or early cancer), we hope to be able to obtain information to address the following questions: </p> <p>4) Do endoscopic therapies prove effective in preventing recurrence of the original lesion? </p> <p>5) Do endoscopic therapies have an effect on rates of development of metachronous oesophageal neoplasia? </p> <p>6) Are there any differences between the intervention and the control therapies in the rates of procedure related mortality (30 day), and early and late complications? </p> <p>7) Are there differences in the quality of life (QoL) experienced after surgery or endoscopic therapy? </p> <p>It was anticipated that there would be few appropriate RCTs and that evidence from other non‐comparative or open trials would form the basis for discussion. We also searched for, and included in the discussion, RCT studies which compare endotherapies with each other. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007334-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007334-sec-0018"></div> <section id="CD007334-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007334-sec-0020"> <h4 class="title">Types of studies</h4> <p>RCTs in which one of the endotherapies is compared with surgery in the treatment of early neoplasia (defined as HGD, or early cancer defined as carcinoma in‐situ, superficially invasive, early cancer or superficial cancer T‐1m and T‐1sm, also commonly referred to as T1a and T1b) on a background of Barrett's oesophagus. All cellular types of cancer were eligible for inclusion (i.e. adenocarcinomas, squamous cell carcinomas and more unusual types) but would be discussed separately owing to their differing evolution and prognosis. </p> </section> <section id="CD007334-sec-0021"> <h4 class="title">Types of participants</h4> <p>Patients of any age and either gender found to have a histologically confirmed diagnosis of early neoplasia (HGD and early cancer) on a background of Barrett's or squamous lined oesophagus. </p> </section> <section id="CD007334-sec-0022"> <h4 class="title">Types of interventions</h4> <p>Endotherapies (the intervention) compared with surgery (the control), all with curative intent. </p> </section> <section id="CD007334-sec-0023"> <h4 class="title">Types of outcome measures</h4> <section id="CD007334-sec-0024"> <h5 class="title">Primary outcomes</h5> <p>In patients with HGD:</p> <p>1. Progression to cancer at one or more years.</p> <p>In patients with early cancer:</p> <p>2. Overall survival at one or more years. All reports of survival will be considered, such as hazard ratios, log rank tests, percentages. </p> </section> <section id="CD007334-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p>In patients with either HGD or early cancer:</p> <p>1. Cancer‐free survival at one, five and, if data are available, 10 years;<br/>2. Progression‐free survival at one, five and, if data are available, 10 years. </p> <p>If data are available for patients with either HGD or early cancer, we shall collect data for the following outcomes: </p> <p>3. Recurrence of original lesion;<br/>4. Development of a metachronous oesophageal cancer;<br/>5. Procedure‐related mortality (30 day);<br/>6. Early complications such as perforation, bleeding, infection;<br/>7. Late complications such as stricture development;<br/>8. QoL.<br/>9. Persistence of Barrett's oesophagus.<br/>Economic data will not be analysed but will be addressed in the discussion. </p> </section> </section> </section> <section id="CD007334-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007334-sec-0027"> <h4 class="title">Electronic searches</h4> <section id="CD007334-sec-0028"> <h5 class="title">Search strategy to locate RCTs</h5> <p>We used the Cochrane Highly Sensitive Search Strategy for identifying RCTs in MEDLINE (<a href="./appendices#CD007334-sec-0060">Appendix 1</a>; <a href="./references#CD007334-bbs2-0054" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>), combined with the search terms in <a href="./appendices#CD007334-sec-0061">Appendix 2</a> to identify RCTs in MEDLINE. The MEDLINE search strategy was adapted for use in the other databases searched (see the corresponding appendix for the search terms used). </p> <p>We searched the following databases in 2008 (<a href="./references#CD007334-bbs2-0122" title="GreenS , TawilA , BarrH , BennettC , BhandariP , DeCaesteckerJ , et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD007334.pub3]">Green 2008</a>): </p> <p> <ul id="CD007334-list-0002"> <li> <p>Cochrane Upper Gastrointestinal and Pancreatic Diseases (UGPD) Group Trials Register;</p> </li> <li> <p>MEDLINE (January 1996 to August 2008) (<a href="./appendices#CD007334-sec-0061">Appendix 2</a>), searched 11 August 2008; </p> </li> <li> <p>EMBASE (January 1996 to week 3 2008) (<a href="./appendices#CD007334-sec-0062">Appendix 3</a>), searched using the RCT filter on July 23 2008 and again, in order to widen the search, without the RCT filter on August 11 2008; </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2008, Issue 3) (<a href="./appendices#CD007334-sec-0063">Appendix 4</a>), searched 24 July 2008; </p> </li> <li> <p>ISI Web of Science (January 2000 to July 2008) (<a href="./appendices#CD007334-sec-0064">Appendix 5</a>), searched 23 July 2008; </p> </li> <li> <p>EBMR (January 2000 to August 2008) (<a href="./appendices#CD007334-sec-0065">Appendix 6</a>), searched 6 August 2008; </p> </li> <li> <p>Controlled Trials mRCT and ISRCTN (January 2000 to July 2008) (<a href="./appendices#CD007334-sec-0066">Appendix 7</a>), searched 23 July 2008; and </p> </li> <li> <p>LILACS (January 2000 to July 2008) (<a href="./appendices#CD007334-sec-0067">Appendix 8</a>), searched 23 July 2008. </p> </li> </ul> </p> <p>The searches were updated in November 2009 in EMBASE, MEDLINE and CENTRAL and Controlled Trials mRCT and ISRCTN. The search for LILACS was updated and re‐run from 1 January 2000 to November 2009 (<a href="./references#CD007334-bbs2-0122" title="GreenS , TawilA , BarrH , BennettC , BhandariP , DeCaesteckerJ , et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD007334.pub3]">Green 2008</a>). We revised the LILACS search strategy to use DeCS (Descriptors in Health Sciences) as it is trilingual (English, Portuguese and Spanish) vocabulary coding. We also simplified the strategy in the hope of finding more relevant citations. Because this was a change from the search strategy published in the protocol of this review, we re‐searched LILACS from January 1 2000 to November 2009. </p> <p>We updated the searches in 2012 as follows:</p> <p> <ul id="CD007334-list-0003"> <li> <p>Ovid MEDLINE(R) (1946 to March week 4 2012);</p> </li> <li> <p>EMBASE (1980 to 2012 week 14);</p> </li> <li> <p>EBMR, CENTRAL (April 2012);</p> </li> <li> <p>Web of Knowledge (v.5.5) (searched 11 April 2012);</p> </li> <li> <p>LILACS (searched 10 April 2012);</p> </li> <li> <p>www.controlled‐trials.com/ (searched 17 May 2012).</p> </li> </ul> </p> </section> <section id="CD007334-sec-0029"> <h5 class="title">Adverse outcomes</h5> <p>We did not do a separate search for adverse events.</p> </section> <section id="CD007334-sec-0030"> <h5 class="title">Language</h5> <p>We did not confine our search to English language publications and translations were sought where necessary. </p> </section> </section> <section id="CD007334-sec-0031"> <h4 class="title">Searching other resources</h4> <p>Reference lists from trials selected by electronic searching were scanned to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in <i>Gut</i> ) and Digestive Disease Week (published in <i>Gastroenterology</i> ) were handsearched. We searched for relevant published trials in The Cochrane UGPD Group, in CENTRAL in <i>The Cochrane Library</i> (November 2009). </p> <section id="CD007334-sec-0032"> <h5 class="title">Grey Literature</h5> <p>We attempted to find unpublished studies through searching grey literature sources (<a href="./references#CD007334-bbs2-0018" title="AugerCP . Information Sources in Grey Literature. 4th edition. London: Bowker-Saur, 1998.">Auger 1998</a>). </p> </section> <section id="CD007334-sec-0033"> <h5 class="title">Handsearching</h5> <p>The Cochrane UGPD Group's trials register, which contains the results of a comprehensive programme of ongoing handsearching of gastroenterology journals and conference proceedings, was searched. </p> </section> <section id="CD007334-sec-0034"> <h5 class="title">Reference lists</h5> <p>We scanned the bibliographies of published studies and reviews for possible references to RCTs. </p> </section> <section id="CD007334-sec-0035"> <h5 class="title">Correspondence</h5> <p>We tried to identify unpublished or on‐going trials, by writing to trial authors who published reports of trials relevant to this review up to 10 years ago, regardless of the trial's inclusion or exclusion in this review. </p> </section> </section> </section> <section id="CD007334-sec-0036"> <h3 class="title" id="CD007334-sec-0036">Data collection and analysis</h3> <section id="CD007334-sec-0037"> <h4 class="title">Selection of studies</h4> <p>Three review authors (SG, CB and JJ) independently reviewed titles and abstracts of references retrieved from the searches and selected all potentially relevant studies. Copies of these articles were obtained, and reviewed independently by the same authors against the inclusion criteria of the study. Two review authors (SG and CB) independently reviewed the results of the updated searches. </p> <p>Authors were not blinded to the names of the trial authors, institutions or journal of publication. There was no disagreement between the authors and they did not approach or appeal to the editorial base of the Cochrane UGPD Group for consensus. We did not identify any studies that met the inclusion criteria. If updated searches retrieved any reports of studies that meet the inclusion criteria for this review, they would have been analysed using the methods detailed in <a href="./appendices#CD007334-sec-0068">Appendix 9</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007334-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007334-sec-0038"></div> <section id="CD007334-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD007334-sec-0040"> <h4 class="title">Results of the search</h4> <p>We searched electronic databases in 2008 and received 2568 reports of potential RCTs. The review authors identified an additional 13 citations. Two hundred and sixty‐five reports were duplicates and were discarded (<a href="#CD007334-fig-0001">Figure 1</a>). No ongoing trials that compared surgery to endotherapy in Barrett's oesophagus were found. </p> <div class="figure" id="CD007334-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007334-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007334.pub5/media/CDSR/CD007334/image_n/nCD007334-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>When the searches were updated in November 2009, a further 571 studies were identified. None of these was an RCT; we formally excluded one of these studies (<a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a>). </p> <p>In April 2012 in total we found 626 new citations from electronic searches (MEDLINE 160, EMBASE 544, CENTRAL 29, LILACS 0, ISI 14). CB and MA screened the abstracts and titles of all the hits and identified 11 potential RCTs, which we obtained in full text. None was an RCT, we discarded five of these newly identified studies and the remaining six were formally excluded (<a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a>; <a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a>; <a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a>; <a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a>; <a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a>; <a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a>). </p> <p>A bibliography search in 2012 identified <a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a>, which we obtained in full text and formally excluded as it was not an RCT, and <a href="./references#CD007334-bbs2-0036" title="ComayD , BlackhouseG , GoereeR , ArmstrongD , MarshallJK . Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Canadian Journal of Gastroenterology2007;21(4):217-22. [PMID: 17431509]">Comay 2007</a>, a cost analysis that we refer to elsewhere in the review (<a href="#CD007334-sec-0045">Discussion</a>). </p> <p>We searched for ongoing clinical trials and identified 153 registered trials. None of these was a comparison of surgery versus endotherapies. We received details of one trial that has not commenced from the principal investigator (<a href="./references#CD007334-bbs2-0014" title="DeCaesteckerJ , RagunathK , SmartH , BarrH , Lovat L BhandariP . BRIDE [Trial not yet registered; funded by RfPB (PB-PG-0711-25066)]. start date 4/2/20132012. ">BRIDE 2012</a>), which we have placed in the <a href="./references#CD007334-bbs1-0002" title="">Studies awaiting classification</a> list until more details are available for a full appraisal. </p> </section> <section id="CD007334-sec-0041"> <h4 class="title">Included studies</h4> <p>No studies met the inclusion criteria.</p> </section> <section id="CD007334-sec-0042"> <h4 class="title">Excluded studies</h4> <p>None of the studies identified in the searches were suitable for inclusion. There were five trials that compared endoscopic with surgical treatment of HGD or early cancer, or both, in Barrett's oesophagus (<a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a>; <a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a>; <a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a>; <a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a>; <a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a>) but all were retrospective. One further excluded study was identified (<a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a>) during the updated searches carried out in November 2009. </p> <p>In 2012 we excluded six studies that we identified from electronic database searches (<a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a>; <a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a>; <a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a>; <a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a>; <a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a>; <a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a>) and a further study (<a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a>) from a bibliography search of <a href="./references#CD007334-bbs2-0075" title="MenonD , StafinskiT , WuH , LauD , WongC . Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterology2010;10:111.">Menon 2010</a>. </p> <p>In total there are 13 excluded studies (see <a href="./references#CD007334-sec-0089" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD007334-sec-0043"> <h3 class="title">Risk of bias in included studies</h3> <p>There were no included studies.</p> </section> <section id="CD007334-sec-0044"> <h3 class="title" id="CD007334-sec-0044">Effects of interventions</h3> <p>We did not perform a meta‐analysis as there were no included studies. We summarised data from the excluded studies in <a href="#CD007334-tbl-0001">Table 1</a>, <a href="#CD007334-tbl-0002">Table 2</a> and <a href="#CD007334-tbl-0003">Table 3</a> and the results from these in the context of treatment for HGD/early cancer lesion within a Barrett's oesophagus are discussed. </p> <div class="table" id="CD007334-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Demographic data</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment modalities investigated</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of patients</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ratio endoscopic: surgical therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Male (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean age years</b> </p> <p><b>(/surgery)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Histological type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up time</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined PDT and EMR vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24:64</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 endotherapy group</p> <p>68 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adenocarcinoma T1m / T1sm (stage 1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PDT vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129:70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> <p>endotherapy group</p> <p>60 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 years</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective from SEER database</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ER, thermal ablation, PDT or a combination vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>742</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99:643</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>endotherapy group</p> <p>68 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All histological types TisN0M0 (stage 0) or T1N0M0 (stage 1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean follow‐up time in SEER database (23.9 (SE 1.8) for endoscopic treatment; 25.3 (SE 0.7) months for surgery </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PDT or EMR vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47:49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> <p>endotherapy group</p> <p>59 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median follow‐up for 48 patients who were operative survivors after resection of HGD was 56 months (range 1‐250 months). No follow‐up data were given for the endoscopy group </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMR, APC, PDT or a combination vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62:32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73% endotherapy group</p> <p>93%  oesophagectomy group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> <p>endotherapy group</p> <p>64 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD or IMC in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean follow‐up for the endoscopic therapy was a median 20 months' with a range of 6 to 84 months. For the surgery group, the median follow‐up was 48 months with a range of 6 to 88 months </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Endoscopic ablation vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>159</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80:70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.7</p> <p>endotherapy group</p> <p>63.1 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Barrett's oesophagus patients who had undergone oesophagectomy or endoscopic ablation. Prior to treatment, 70.4% of patients were diagnosed as HGD/IMC or T1sm, but 29.6% of participants were stage T2 or greater). </p> <p>Post‐oesophagectomy pathology was only reported in the participants with HGD or IMC. Disease was limited to the mucosa in 80% (24 of 30 participants). Efficacy was not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No long‐term outcomes reported (not the primary focus of the study)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR + RFA (therapeutic and salvage) vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 in total, 73 reported in detail.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33:40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 (ratio 5.4:1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median age 65 years (range 29 to 86 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrett's oesophagus with early malignant lesions, defined as HGD, IMC and submucosal T1 adenocarcinoma. No further details given in study report, as 1 patient had T1N1 disease, the study may have included patients with more or less advanced disease </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Described as a 10‐year audit but length of follow‐up not clear (very short report)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective data from 2 high‐volume centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ER + APC vs. en bloc transthoracic oesophageal resection with 2‐field lymphadenectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76:38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 endotherapy group</p> <p>97 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median age</p> <p>62.2 endotherapy group</p> <p>62.7 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Matched cases with respect to age, gender, infiltration depth (pT1m1‐3), differentiation grade (G1/2 vs. 3) and follow‐up period </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1 years endotherapy group</p> <p>3.7 years surgery group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective cross‐sectional review by questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endotherapy vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81:33 (66 endoscopy and 29 surgery responded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83 endotherapy group</p> <p>82 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.1 (SD 8.2) endotherapy group</p> <p>63 (SD 9.5) surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD, early cancer (cancer<br/>limited to the mucosa [T1m] or superficial submucosa [T1sm1]), or both </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 to 60 months after treatment</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endotherapy (various) vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (40 responded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27:13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 endotherapy group</p> <p>93 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 endotherapy group</p> <p>63 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrett's oesophagus with HGD or IMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear, study examines cases from 1998 to 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR vs. oesophagectomy (2/3 transhiatal; 1/3 transthoracic)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (31 had oesophagectomy without CRT; 15 had EMR without CRT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15:31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.8 endotherapy group</p> <p>92.3 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.9 endotherapy group</p> <p>67.1 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Submucosal oesophageal adenocarcinoma (T1b oesophageal adenocarcinomas)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective review of pathology database</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>APC vs. oesophagectomy (vs. surveillance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 (13 having APC or surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5:8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 endotherapy group</p> <p>87.5</p> <p>surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 endotherapy group</p> <p>58 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD and medically unfit or chose not to have oesophagectomy in APC group.</p> <p>Persistent HGD on repeat biopsies done after a mean interval of 2 months in surgery group. </p> <p>Results reported for HGD groups (not adenocarcinoma) only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months APC, up to 60 months oesophagectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR vs. oesophagectomy (transthoracic en bloc, transhiatal, minimally invasive, or vagus sparing) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40:61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 endotherapy group</p> <p>70 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 endotherapy group</p> <p>68 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD or IMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 and 5 years</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>APC: argon plasma coagulation; CRT: chemoradiotherapy; EMR: endoscopic mucosal resection; ER: endoscopic resection; HGD: high‐grade dysplasia; IMC: intramucosal cancer; PDT: photodynamic therapy; SD: standard deviation; SE: standard error; SEER: Surveillance, Epidemiology, and End Results. </p> </div> </div> <div class="table" id="CD007334-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Primary outcome: survival</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival in endoscopic treatment group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival in surgical group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significantly different?</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at end of follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92% at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97% at 19 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91% at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.5% at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median cancer‐free survival</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between the 2 groups (P = 0.41)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at 5 and 10 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% at 5 years (disease specific 93%), 64% at 10 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted 4‐year survival</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89% (0 due to oesophageal cancer)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (none due to oesophageal cancer)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Vital status" was reported in <a href="#CD007334-tbl-0001">Table 1</a> of this study, for the aggregated group of all patients, regardless of cancer stage (54% of patients were ≥ stage T2). There were no significant differences (P = 0.60) between the numbers of deceased participants in the oesophagectomy (10%) or ablation (13%) groups. The interval between treatment and death and cause of death were not reported </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival 1, 3 and 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99% at 1 year</p> <p>96% at 3 years</p> <p>89% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97% at 1 year</p> <p>93% at 3 years</p> <p>93% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences between the 2 groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported, not the focus of the study (QoL focus)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median overall survival duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (note: survival rates are for the whole group including those who had CRT in addition to EMR or surgery). In multivariate Cox modelling, age, co‐morbidities sex and oesophagectomy were not associated with survival duration. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear (not the focus of the study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62% at mean 18.5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear, not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival at 3 and 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94% at 3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94% at 3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CRT: chemoradiotherapy; EMR: endoscopic mucosal resection; QoL: quality of life.</p> </div> </div> <div class="table" id="CD007334-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Secondary outcomes</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Cancer‐free survival</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Treatment failures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Procedure‐related mortality (30 day)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Complications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>QoL</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% (20/24) remained free of cancer at 12 ± 2 and 19 ± 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients remained free of cancer at 12 ± 2 and 19 ± 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent cancer at first follow‐up 17% (4/24 patients). No later recurrence</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stricture: 8%</p> <p>Photo‐</p> <p>sensitivity: 8%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stricture: 16%</p> <p>Anastomotic leak: 8%</p> <p>Wound infection: 8%</p> <p>Dumping syndrome: 5%</p> <p>Empyema (pus in the pleural cavity): 3%</p> <p>Blood transfusion: 3%</p> <p>Atrial fibrillation: 3%</p> <p>Aspiration: 2%</p> <p>Chylothorax (lymphatic effusion in the pleural cavity): 2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference between groups but tendency towards lower cancer‐free survival in endoscopic therapy group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD eliminated: at 1 year: 88%; at 3 years: 86%</p> <p>HGD detected within 12 months: 26% (33/129) i.e. failed initial therapy and retreated, HGD eradicated in 70% of these. </p> <p>Recurrence of HGD (detected after 12 months free of HGD): 7.8% (10/129)</p> <p>Cancer detected during follow‐up (up to 18 months after PDT): 6.2% (8/129)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No early complications</p> <p>Stricture formation: 27%</p> <p>Photosensitivity: 60%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38% Postoperative morbidity</p> <p>Stricture formation: 12.6%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No QoL data, performance score only given</p> <p>ECOG PS?1 in 73% at end of FU*</p> <p>Proportions unchanged from pre‐therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No QoL data, performance score only given</p> <p>ECOG PS?1 in 94% at end of FU*</p> <p>Proportions unchanged from pre‐therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(Only oesophageal cancer‐specific cause of death considered)</p> <p>56 months (50 to 61 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 months (57 to 67 months) (no significant difference)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/42 PDT and 2/5 EMR patients had recurrent HGD/cancer after mean 13.5 months. 1 developed metastatic spread but 0 died during follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/49 patients died from recurrent disease</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (cerebrovascular accident in postoperative period)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anastomotic leaks: 4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant bleeding: 3%, perforation: 2%, oesophageal stenosis: 31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptomatic anastomotic leakage: 15 %, pulmonary<br/>problems: 30 %, serious infections: 15 % and vocal cord<br/>paralysis: 15 %. Anastomotic<br/>stenosis in 37% during follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QoL measured (SF‐36, EORTC‐QLQ‐C30, EORTC‐QLQ‐OES18 questionnaires). HADS, WOCS.</p> <p>Endoscopy patients reported more fear of recurrence on the WOCS than surgery patients (P = 0.003). </p> <p>No significant differences were found between the 2 groups on the other outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgery patients had significantly more eating problems (OR 18.3; P &lt; 0.001) and reflux symptoms (OR 3.4; P = 0.05) on the EORTC‐OES18 questionnaire </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Residual Barrett's segment in 44%,</p> <p>persistent dysplasia in 13%,</p> <p>progression to cancer in 6%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Residual Barrett's segment in 3%,</p> <p>persistent dysplasia in 3%,</p> <p>no progression to cancer</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%: 1 patient died from diverticulitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major: 8%</p> <p>Minor: 32%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major: 13%</p> <p>Minor: 66% (significantly different)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In patients treated by EMR + RFA, there was 100% disease control; 72% had complete eradication of Barrett's disease, and 1 patient </p> <p>represented with low‐grade dysplasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8% surgical patients relapsed with HGD or cancer and 1 patient with T1N1 disease died of recurrent disease </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear from study report</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear from study report</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% mortality and 32% morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% morbidity from EMR + RFA (statistically significant compared with surgery P=0.001)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.7% at 4.1 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3.7 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6% (repeat endoscopic treatment was successful in all patients who experienced disease recurrence </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No deaths from tumour‐related disease during follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality at 40 days 2.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minor complication in 17% (bleeding managed by clipping or injection). No major complications (severe bleeding, perforation stenosis) observed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32% major complications. including anastomotic leakage, pneumonia, multiple organ failure following sepsis, cardiac problems </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36: no significant differences compared with surgery</p> <p>GIQLI: higher (better) scores among ASA Class 1 and 2 endotherapy patients compared with surgery (not statistically significant) and higher among young endotherapy patients than young surgery patients </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SF‐36: no significant differences other than superior physical functioning in patients 65 years of age and older </p> <p>GIQLI: no significant differences in scores of older patients for surgery and endotherapy or SAS 3 patients. </p> <p>Negative QoL impact appears to be greater for younger patients undergoing surgery.</p> <p>(overall QoL scores: "QOL scores among EG and ET groups were not significantly different than sex age‐matched controls” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In group who had EMR as only therapy, 21.4% had cancer recurrence at 45 months follow‐up (remaining 11 had mean cancer‐free periods of 21 months) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 death at 34 days owing to anastomotic leak (with 'do not resuscitate' order)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/5 went on to develop metastatic adenocarcinoma<br/>at 9 and 12 months follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/8 patients developed recurrent adenocarcinoma at 22 and 60 months after surgery, 1 of whom died </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative morbidity in 4 patients (pneumonia, adult respiratory distress syndrome, pneumothorax) 2/8 developed postoperative strictures at 3 to 6 months' postsurgery requiring ongoing dilation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3 years;</p> <p>100% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3 years;</p> <p>88% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% had new or metachronous cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39% had complications including long‐term complications of anastomotic strictures, ventral hernias, reflux, postprandial dumping or diarrhoea </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*ECOG PS 0 = fully active, able to carry on all pre‐disease performance without restriction.</p> <p>ECOG PS 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. </p> <p>ASA: American Society of Anesthesia; EMR: endoscopic mucosal resection; EORTC‐QLQ: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; FU: fluorouracil; GIQLI: Gastrointestinal Quality of Life Index; HADS: Hospital Anxiety and Depression Scale; OR: odds ratio; PDT: photodynamic therapy; QoL: quality of life; RFA: radiofrequency ablation; SF‐36: 36‐item Short Form; WOCS: Worry Of Cancer Scale. </p> </div> </div> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007334-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007334-sec-0045"></div> <p>There are currently no RCTs comparing surgery with endoscopic therapy for early cancer and HGD in Barrett's oesophagus. This discussion is based on available evidence derived from reports of non‐randomised studies. It is difficult to draw definitive conclusions from the data obtained from non‐RCTs owing to selection bias. </p> <p>Updated searches will be carried out on a regular basis and if RCTs or potential RCTs become available they will be assessed and, where appropriate, incorporated into an updated review. If further details are required to assess the trials, for example method of randomisation, the study investigators will be contacted to obtain further details. </p> <section id="CD007334-sec-0046"> <h3 class="title" id="CD007334-sec-0046">Summary of main results</h3> <p>We excluded 13 published studies that compared surgery with endotherapy in early cancer and HGD in Barrett's oesophagus (<a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a>; <a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a>; <a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a>; <a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a>; <a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a>; <a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a>; <a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a>; <a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a>; <a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a>; <a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a>; <a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a>; <a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a>; <a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a>) as all were retrospective and non‐randomised. All of these excluded studies are likely to be biased as endoscopic therapy has, until very recently, been offered largely to those considered unfit for surgery owing to age and frailty, hence the decision to treat by endoscopic methods was generally not based on the stage of the disease. In all of the excluded studies, patients in the endotherapy groups were older than in the surgical groups, and had shorter Barrett's segments or less invasive disease, or both. In <a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a>, the study investigators comment on this, stating that in their study, participants in the endotherapy group were older but "not necessarily sicker", and that "endotherapy was initially reserved for poor surgical candidates and only recently have younger healthier patients been referred for consideration of non‐surgical treatment". Other factors may influence the treatment pathway. In a review of cases between 2003 and 2007, <a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> concluded that patients with Barrett's HGD or IMC, who were aged 60 years or under, and who had a cancer stage of T1sm or greater were more likely to be treated by oesophagectomy. Even when the age and cancer stage were controlled for, patients were more likely to be treated by oesophagectomy if the initial consultation was performed by a surgeon. </p> <p>For healthcare providers such as the National Health Service (NHS) in the UK, there are considerations in terms of the organisation of care for patients who have high‐grade oesophageal dysplasia such as implementation of new technologies and the need for repeat observations and treatments. In 2012 the BAD CAT (Barrett's and Dysplasia Cancer Action Taskforce) consensus group created evidence‐based consensus statements for the management of patients with Barrett's oesophagus and early‐stage oesophageal adenocarcinoma. This approach identified important clinical features of HGD in Barrett's oesophagus and areas for future studies where management could be made more consistent or improved (<a href="./references#CD007334-bbs2-0021" title="BennettC , VakilN , BergmanJ , HarrisonR , OdzeR , ViethM , et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a delphi process. Gastroenterology2012;143(2):336-46. [PMID: 22537613]">Bennett 2012</a>). </p> <p>In this review, with the limited data available and lack of published RCTs comparing endoscopic treatment with oesophagectomy, it is impossible to reach firm comparative conclusions. </p> </section> <section id="CD007334-sec-0047"> <h3 class="title" id="CD007334-sec-0047">Overall completeness and applicability of evidence</h3> <p>We were unable to find any RCTs of direct comparisons of surgery versus endotherapies for the treatment of early cancer and HGD in Barrett's oesophagus. Therefore the studies that we identified and excluded are not sufficient to address all of the objectives of the review. However the results of other studies that address risk of progression, effects of treatment in terms of cure, progression and complications are available from non‐randomised studies and we have attempted to summarise some of these data here, with reference to the studies that we excluded. </p> <section id="CD007334-sec-0048"> <h4 class="title">Risk of progression from Barrett's oesophagus to cancer</h4> <p>Treating all patients with Barrett's oesophagus is currently unfeasible as it occurs in at least 0.5% of the UK population (and is not supported by number‐needed‐to‐treat analyses) (<a href="./references#CD007334-bbs2-0032" title="CameronAJ , ZinsmeisterAR , BallardDJ , CarneyJA . Prevalence of columnar-lined (Barrett's) oesophagus. Comparison of population based clinical and autopsy findings. Gastroenterology1990;99(4):918-22.">Cameron 1990</a>). Progression from non‐dysplastic Barrett's oesophagus to malignancy is rare. Large studies from Northern Ireland and Denmark suggest a malignant progression rate of 0.12% to 0.39% of patients per year (<a href="./references#CD007334-bbs2-0022" title="BhatS , ColemanHG , YousefF , JohnstonBT , McManusDT , GavinAT , et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. Journal of the National Cancer Institute2011;103(13):1049-57.">Bhat 2011</a>; <a href="./references#CD007334-bbs2-0061" title="Hvid-JensenF , PedersenL , DrewesAM , SroensenHT , Funch-JensenP . Incidence of adenocarcinoma among patients with Barrett's esophagus. New England Journal of Medicine2011;365(15):1375-83. [0028-4793]">Hvid‐Jensen 2011</a>; <a href="./references#CD007334-bbs2-0121" title="YousefF , CardwellC , CantwellMM , GalwayK , JohnstonBT , MurrayL . The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. American Journal of Epidemiology2008;168(3):237-49.">Yousef 2008</a>), although these may be underestimates as the studies defined Barrett's histologically rather than endoscopically and are therefore likely to have included a number of patients without true Barrett's. The most common type of metaplastic epithelium, specialised intestinal metaplasia (intestinalisation), is considered to have a major potential to develop into adenocarcinoma. Some studies have suggested that genetic changes play a key role in this progression to cancer. Adenocarcinoma can develop in Barrett's oesophagus with these genetic changes even in the absence of intestinalisation (<a href="./references#CD007334-bbs2-0066" title="KeltyCJ , GoughMD , Van WykQ , StephensonTJ , AckroydR . Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scandinavian Journal of Gastroenterology2007;42(11):1271-4.">Kelty 2007</a>; <a href="./references#CD007334-bbs2-0072" title="LiuW , Hahn HodzeRD , GoyalRK . Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell containing epithelium. American Journal of Gastroenterology2009;104(4):816-24.">Liu 2009</a>). It is hoped that research in progress will identify appropriate strategies for risk assessment, treatment and surveillance in this population (<a href="./references#CD007334-bbs2-0068" title="KondaVJ , WaxmanI . Endotherapy for Barrett's esophagus. American Journal of Gastroenterology2012;107(6):827-33. [PMID: 22488078]">Konda 2012</a>). </p> <p>There is marked variation in the reported malignant potential of LGD. <a href="./references#CD007334-bbs2-0109" title="SkacelM , PetrasRE , GramlichTL , SigelJE , RichterJE , GoldblumJR . The diagnosis of low grade dysplasia in Barrett's esophagus and its implication for disease progression. American Journal of Gastroenterology2000;95(12):3383-7.">Skacel 2000</a> followed 25 patients with LGD for 26 months and found that 8% had persistent LGD, 60% regressed and 28% went on to develop HGD or adenocarcinoma (4% were indefinite for dysplasia at follow‐up). <a href="./references#CD007334-bbs2-0103" title="SharmaP , FalkGW , WestonAP , RekerD , JohnstonM , SamplinerRE . Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology2006;4(5):566-72.">Sharma 2006</a> followed 156 patients with LGD for a mean of 4.1 years and reported stable LGD in 21%, regression in 66% and progression to HGD or cancer in 13%. These data support an earlier audit of a Barrett's epithelium surveillance database, where one in 10 cases of LGD progressed to cancer over an observation period of five years (<a href="./references#CD007334-bbs2-0020" title="BasuKK , PickB , deCaesteckerJS . Audit of a Barrett's epithelium surveillance database. European Journal of Gastroenterology and Hepatology2004;16:1-5.">Basu 2004</a>). However, other studies have shown progression rates below 5% (<a href="./references#CD007334-bbs2-0117" title="WaniS , MathurS , SharmaP . How to manage a Barrett's esophagus patient with low-grade dysplasia. Clinical Gastroenterology and Hepatology2009;1:27-32.">Wani 2009</a>). In one prospective cohort study of 713 patients with Barrett's oesophagus, including 111 with LGD, which reported that, compared to non‐dysplastic disease, LGD was a significant risk factor for progression to HGD or adenocarcinoma (risk ratio (RR) 9.7; 95% confidence interval (CI) 4.4 to 21.5) (<a href="./references#CD007334-bbs2-0107" title="SikkemaM , deJongePJ , SteyerbergEW , KuipersEJ . Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology2010;8(3):235-44.">Sikkema 2010</a>). </p> <p>This variation in the reported malignant potential of LGD partly reflects difficulties in establishing an accurate histological diagnosis. It has been demonstrated that non‐dysplastic Barrett's oesophagus is frequently over‐diagnosed as LGD by non‐specialist pathologists (<a href="./references#CD007334-bbs2-0039" title="CurversWL , Ten KateFJ , KrishnadathKK , VisserM , ElzerB , BaakLC , et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. American Journal of Gastroenterology2010;105(7):1523-30. [0002-9270]">Curvers 2010</a>). The study authors concluded that the true significance of LGD may be underestimated by the majority of studies that have relied on single pathologist reporting. </p> <p>In this review, we chose not to address LGD in Barrett's oesophagus. We included both HGD and IMC (mucosal neoplasia) in this review, owing to the suboptimal techniques available to differentiate between them. In addition, their biological behaviour is similar, as both have a low risk of nodal spread. </p> <p>Literature suggests that, in those with biopsy‐confirmed HGD, the rate of submucosally invasive cancer is 12.7% in those with endoscopically visible HGD and 3% for those with no detectable lesion (<a href="./references#CD007334-bbs2-0067" title="KondaVJ , RossAS , FergusonMK , HartJA , LinS , NaylorK , et al. Is the risk of concomitant invasive esophageal cancer in high grade dysplasia in Barrett's esophagus overestimated?Clinical and Experimental Pathology2008;6(2):159-64.">Konda 2008</a>). There is variability in the reported risk of lymph node metastases in patients with intramucosal and submucosal (T1) oesophageal adenocarcinoma, which may be accounted for by differences in depth of invasion, size, presence of lympho‐vascular invasion and tumour grade. One retrospective review of 126 T1a and T1b tumours reported that although lymph node metastases were rare (1.3%) with intramucosal tumours, submucosal invasion of any extent carried a significant risk of lymph node metastases (and is thus unsuitable for endoscopic treatment) (<a href="./references#CD007334-bbs2-0071" title="LeersJM , DeMeesterSR , OezcelikA , KlipfelN , AyaziS , AbateE , et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Annals of Surgery2011;253(2):271-8. [PMID: 21119508]">Leers 2011</a>). This has not been the experience of others who have concluded that superficial submucosal invasion is low risk for metastases (<a href="./references#CD007334-bbs2-0016" title="Alvarez HerreroL , PouwRE , vanVilsterenFG , ten KateFJW , VisserM , van Berge Henegouwen, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy2010;42(12):1030-6.">Alvarez Herrero 2010</a>). Careful histopathology of ER specimens should influence the decision whether to treat endoscopically or by oesophagectomy (<a href="./references#CD007334-bbs2-0087" title="PetersFP , BrakenhoffKP , CurversWL . Histological evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's oesophagus. Gastrointestinal Endoscopy2008;67:604-9.">Peters 2008</a>). Mortality rates for oesophagectomy may exceed 2%, hence a small risk of lymph node metastases may be acceptable after endoscopic therapy. </p> </section> <section id="CD007334-sec-0049"> <h4 class="title">Surgery or endotherapy?</h4> <p>If visible lesions suspicious of dysplasia are found in the setting of Barrett's oesophagus, ER should be performed in order to obtain an accurate histological diagnosis. A variety of options including resection or ablative therapies, followed by adequate surveillance, are available to treat the epithelium. </p> <p>Surgical therapies, although effective, are costly and carry appreciable patient mortality and morbidity. Ablative endotherapies allow restoration of the normal squamous lining and thereby remove both existing dysplasia and the potential for development of dysplasia (<a href="./references#CD007334-bbs2-0097" title="SamplinerR , FennertyMB , GarewalH . Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation. Gastrointestinal Endoscopy1996;44:523-5.">Sampliner 1996</a>). In patients with HGD, endotherapies may offer an alternative to oesophagectomy with comparable survival, lower mortality and morbidity (<a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a>, <a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a>), and less disruption of QoL (<a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a>; <a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a>), especially since patients with Barrett's oesophagus have considerable co‐morbidity (<a href="./references#CD007334-bbs2-0077" title="MoayyediP , BurchN , Akhtar-DaneshN , EnagantiSK , HarrisonR , TalleyNJ , et al. Mortality rates in patients with Barrett's oesophagus. Alimentary Pharmacology and Therapeutics2008;27(4):316-20.">Moayyedi 2008</a>). </p> <p>Post‐oesophagectomy mortality and morbidity are important issues; <a href="./references#CD007334-bbs2-0041" title="DeMeesterSR . New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal spearing esophagectomy. Annals of Thoracic Surgery2008;85:S747-90.">DeMeester 2008</a> suggested that quoted high postoperative mortality rates were not supported by more recent studies of patients with HGD or early cancer who were treated by oesophagectomy, although there is a volume to performance relationship (<a href="./references#CD007334-bbs2-0034" title="ChangAC , BurkmeyerJD . The volume-performance relationship in esophagectomy. Thoracic Surgery Clinics2006;16:87-91.">Chang 2006</a>). In one retrospective case series, vagal‐sparing oesophagectomy was associated with less peri‐operative morbidity, a shorter hospital stay and fewer late complications such as weight loss, diarrhoea and dumping, than other surgical techniques (<a href="./references#CD007334-bbs2-0088" title="PyerC , De MeesterS , RizzettoC , BansalN , TangA , AyaziS , et al. Vagal sparing esophagectomy. The ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Annals of Surgery2007;246(4):665-74.">Peyre 2007</a>). In that study, postoperative mortality was similar for all types of surgical resection (30‐day mortality percentage; vagal‐sparing 2%, transhiatal 5%; en‐bloc 0%) and survival was reported to be excellent (percentage survival over 60 months, in 85 patients diagnosed with cancer, all‐cause mortality: vagal sparing 89%; transhiatal 65%; en bloc 95%). While oesophagectomy can potentially offer the chance of complete resection of diseased tissue in patients with HGD or early (intramucosal) adenocarcinoma, recurrent Barrett's metaplasia or neoplasia may still appear after resection with curative intent (<a href="./references#CD007334-bbs2-0120" title="WolfsonH , HemmingerL , DeVaultK . Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterology2004;4:18. [DOI: 10.1186/1471-230X-4-18]">Wolfson 2004</a>). </p> <p>While different surgical techniques used for oesophagectomy offer broadly similar results, the endotherapy arm of many of the reports reviewed here were found to be much more heterogeneous. Published studies do consistently report endoscopic therapy to be safe and effective. For example in <a href="./references#CD007334-bbs2-0101" title="ShaheenNJ , SharmaP , OverholtB , WolfsenH , SamplinerR , WangK , et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. New England Journal of Medicine2009;360:2277-88.">Shaheen 2009</a>, a multicentre, sham‐controlled randomised trial, participants received either RFA or a sham procedure. In patients with dysplastic Barrett's oesophagus, RFA was associated with a high rate of complete eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression, and few serious adverse effects. Medium‐term follow‐up data have demonstrated that these effects are durable at three years (<a href="./references#CD007334-bbs2-0102" title="ShaheenNJ , OverholtBF , SamplinerRE , WolfsenHC , WangKK , FleischerDE , et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology2011;141(2):460-8. [0016-5085]">Shaheen 2011</a>). </p> <p>While we found no RCTs that directly compared the results of surgery versus endotherapies, <a href="./references#CD007334-bbs2-0017" title="AttwoodS , LewisC , CaplinS , HemmingK , ArmstrongG . Argon beam photocoagulation as therapy for high grade dysplasia in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1(4):258-63.">Attwood 2003</a> followed 29 patients with Barrett's‐related HGD who were deemed unfit for or declined surgery, instead undergoing argon beam photocoagulation. He showed that survival over seven years was not different to the general age‐ and sex‐matched population. This would suggest that, in those patients unable or unwilling to undergo oesophagectomy, endoscopic therapy offers a significant survival benefit over no therapy at all. <a href="./references#CD007334-bbs2-0051" title="GreensteinA , WisniveskyJ , LitleV . Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Diseases of the Esophagus2008;21(8):673-8. [DOI: 10.111/j.1442-2050.2008.00832]">Greenstein 2008</a> used the Surveillance, Epidemiology, and End Results (SEER) cancer registry data to compare survival in patients having either endoscopic therapy or no therapy. There was a significantly better oesophageal cancer‐related survival in the endoscopically treated group. It cannot be assumed that all of this group were deemed unfit for surgery, but non‐cancer‐related survival curves were similar between the groups suggesting similar co‐morbidities. </p> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> concluded that "both endotherapy and esophagectomy can effectively treat high‐grade dysplasia and intramucosal carcinoma associated with Barrett's esophagus". Endotherapy is associated with a higher risk of tumor progression, although this is uncommon. Esophagectomy incurs higher initial costs and results in more frequent minor complications but is usually curative. In this study, exclusion of the 'unfit for surgery' participants resulted in only 3% developing cancer (5% HGD) at the latest follow up (with no major complications and 27% minor complications), significantly fewer compared with the surgical group. One retrospective matched cohort comparison of oesophagectomy versus ER and APC in IMC reported effective treatment outcomes for both strategies after four years of follow‐up (<a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a>). Complete remission of Barrett's was achieved in all patients in the surgical group and 98.7% in the ER group. 90 day mortality was 2.6% following surgery and 0% following endotherapy and major complications were only observed in the surgical group (32%). No tumour‐related mortality was observed in either group demonstrating that both strategies provided effective treatment in the medium term. </p> </section> <section id="CD007334-sec-0050"> <h4 class="title">Adverse effects and treatment failure</h4> <p>Complications may arise as a result of endotherapy and there is the possibility of treatment failure as local endoscopic therapies can leave much of the oesophagus intact and often untreated. </p> <p>A review of 12 publications on ER for early Barrett's neoplasia (<a href="./references#CD007334-bbs2-0084" title="PechO , MayA , RabensteinT , EllC . Endoscopic resection of early oesophageal cancer. Gut2007;56:1625-34.">Pech 2007</a>) showed recurrence rates of 0% to 21%, minor complications in 0% to 46% and few major complications. <a href="./references#CD007334-bbs2-0045" title="EllC , MayA , PechO , GossnerL , GuenterE , BehrensA , et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Clinical Endoscopy2007;65(1):3-10.">Ell 2007</a> published single centre results of ER in 100 consecutive patients with early Barrett's adenocarcinoma (total 144 resections) showing no major complications, 11 minor complications (all bleeds without decrease in haemoglobin (Hb) &gt; 2 g/dL) and local remission in 99% of patients after 1.9 months with a five‐year survival rate of 98% (both of the patient deaths were from unrelated causes). </p> <p>One retrospective matched cohort comparison of oesophagectomy versus ER and APC in T1 cancer reported cancer‐free remission for both strategies after four years of follow‐up (<a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a>). Complete remission of Barrett's was achieved in all patients in the surgical group and 98.7% in the ER group. Ninety‐day mortality was 2.6% following surgery and 0% following endotherapy and major complications were only observed in the surgical group (32%). No tumour‐related mortality was observed in either group demonstrating that both strategies provided effective treatment in the medium term. </p> <p>When focused local therapy is used to remove an HGD/early cancer lesion within a Barrett's segment, there often remains a significant amount of residual Barrett's. After endotherapy, the remaining Barrett's has a high malignant potential and small patches of early dysplasia can easily be missed at initial treatments. In patients who have already developed an area of HGD/early cancer, it is likely that the residual Barrett's has a greater malignant potential (field change effect) than in those who have never developed a dysplastic lesion. Many studies have therefore used a combination of local therapies, for example EMR to remove the HGD/early cancer lesions and wide‐field ablation modalities (most commonly PDT or RFA) to treat the residual Barrett's in an attempt to reduce the rate of metachronous lesions found at follow‐up. </p> <p>One randomised study of HGD in Barrett's by <a href="./references#CD007334-bbs2-0082" title="OverholtB , WangK , BurdickS , LightdaleC , KimmeyM , NavaH , et al. Five-year efficacy and safety of photodynamic therapy with photofrin in Barrett's high-grade dysplasia. Clinical Endoscopy2007;66(3):460-8.">Overholt 2007</a> compared PDT plus omeprazole to omeprazole alone and demonstrated that at five years those in the PDT group were less likely to have detectable HGD (77% versus 39%) or cancer (29% versus 15%). Photosensitivity reactions and oesophageal strictures were reported as adverse events, but no long‐term effects of oesophageal strictures or photosensitivity reactions were seen by the end of the study. There is some concern that PDT may simply 'bury' the pre‐malignant tissue under neo‐squamous epithelium (<a href="./references#CD007334-bbs2-0076" title="Mino-KenudsonM , Ban, S, OhanaM , PuricelliW , DeshpandeV , Shimizu, M et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. American Journal of Surgical Pathology2007;31:403-9.">Mino‐Kenudson 2007</a>), although these areas seem to have a low malignant potential (<a href="./references#CD007334-bbs2-0023" title="BiddlestoneLR , BarhamCP , WilkinsonSP , BarrH , ShepherdNA . The histopathology of treated Barrett's oesophagus: squamous re-epithelialisation following acid suppression, laser and photodynamic therapy. American Journal of Surgical Pathology1998;22(2):239-45.">Biddlestone 1998</a>; <a href="./references#CD007334-bbs2-0057" title="HornickJL , Mino-KenudsonM , LauwersGY , LiuW , GoyalR , OdzeRD . Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. American Journal of Gastroenterology2007;103(1):38-47.">Hornick 2007</a>) and may simply atrophy over time (<a href="./references#CD007334-bbs2-0056" title="HornickJL , BlountPL , SanchezCA , CowanDS , AyubKM , MaleyCC , et al. Biological properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. American Journal of Surgical Pathology2005;29:372-80.">Hornick 2005</a>). PDT also has a relatively high rate of complications (e.g. strictures and photosensitisation). One retrospective review of 50 patients treated by PDT for HGD or early oesophageal cancer showed there was no procedure‐related mortality, but 42% of the patients developed oesophageal stricture (<a href="./references#CD007334-bbs2-0065" title="KeeleySB , PennathurA , GoodingW , LandreneauRJ , ChristieNA , LuketichJ . Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. American Journal of Surgical Oncology2007;14(8):2406-10.">Keeley 2007</a>). <a href="./references#CD007334-bbs2-0027" title="BronnerMP , OverholtBF ,  TaylorSL , HaggittR , WangK , BurdickJS , et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology2009;136(1):56-64.">Bronner 2009</a> reported that squamous overgrowth following PDT did not obscure the most advanced neoplasia in any patient. </p> <p>Recurrence or metachronous lesions occur relatively frequently but repeat local therapy is usually possible and successful. <a href="./references#CD007334-bbs2-0099" title="SchnellTG , SontagSJ , ChejfecG , AranhaG , MetzA , O'ConnellS , et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology2001;120:1608-19.">Schnell 2001</a> demonstrated that the risk of cancer developing from HGD after the first year was 16% in a group of 75 people followed up for a mean of seven years (managing these patients with a strategy of frequent endoscopic surveillance with biopsies). <a href="./references#CD007334-bbs2-0074" title="MayA , GossnerL , PechO , FritzA , GunterE , MayerG , et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute phase and intermediate results of a new treatment approach. European Journal of Gastroenterology2002;14:1085-91.">May 2002</a> showed that in a group of 115 patients with dysplastic areas, most of whom had early cancer (96 early cancer, 19 HGD), 30% developed a metachronous cancer after undergoing local therapy, usually EMR alone (EMR alone in 70, PDT alone in 32, EMR and PDT in 10 and APC alone in three) over a mean follow‐up period of 34 months. A study by <a href="./references#CD007334-bbs2-0083" title="PechO , BehrensA , MayA , GossnerL , ViethM , StolteM , et al. Curative endoscopic therapy for Barrett's early cancer and high grade dysplasia: long-term results in 304 patients. Gastrointestinal Endoscopy2006;63(5):AB83.">Pech 2006</a> including 304 patients undergoing ER, PDT, or both, followed for a mean of 69.5 months reported tumour‐related deaths in two inoperable patients. Complications in this study included bleeding in 11% and stricture formation in 3.3%, all of which were managed endoscopically. <a href="./references#CD007334-bbs2-0085" title="PechO , BehrensA , MayA , NachbarL , GossnerL , RabensteinT , et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut2008;57:1200-6.">Pech 2008</a> reported long‐term results from a cohort of patients with Barrett's neoplasia, who were treated endoscopically. Three hundred and forty‐nine patients were followed up for a mean of 63.6 months. A complete response was seen in 96.6% and surgery was necessary in 3.7% after endoscopic therapy failed. Metachronous lesions developed during the follow‐up in 74 patients (21.5%); 56 died of concomitant disease, but none died of Barrett's neoplasia. The calculated five‐year survival rate was 84%. The reason for the high rate of recurrence seemed to be a result of the undetected neoplasia in the Barrett's segment after endoscopic therapy. <a href="./references#CD007334-bbs2-0079" title="MossA , BourkeMJ , HouriganLF , GuptaS , WilliamsSJ , TranK , et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. American Journal of Gastroenterology2010;(6):1276-83. [0002-9270]">Moss 2010</a>, in Australia, demonstrated the effects of ER on histological grade and stage of adenocarcinoma, in a prospective study at two centres (N = 75) using ER for HGD or oesophageal adenocarcinoma, there was no recurrence at resected sites, 11% developed metachronous lesions and five developed submucosal invasion treated by oesophagectomy. There were no deaths due to adenocarcinoma. The study authors concluded that ER altered histological grade or local T stage and resulted in reduced oesophagectomy rates. </p> <p>There are promising results from using either circumferential ER (<a href="./references#CD007334-bbs2-0047" title="GiovanniniM , BoriesE , PesentiC , MountardierV , MongesG , DanisiC , et al. Circumferectial endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer, preliminary results in 21 patients. Endoscopy2004;36(9):782-7.">Giovannini 2004</a>; <a href="./references#CD007334-bbs2-0086" title="PetersFP , KaraMA , RosmolenWD , Ten KateFJW , KrishnadathKK , LanschotJJB , et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. American Journal of Gastroenterology2006;101:1449-57.">Peters 2006</a>) or RFA (<a href="./references#CD007334-bbs2-0048" title="GondrieJJ , PouwRE , SondermeijerCM , PetersFP , CurversWL , RosmolenWD , et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy2008;40(5):359-69.">Gondrie 2008a</a>; <a href="./references#CD007334-bbs2-0049" title="GondrieJJ , PouwRE , SondermeijerCM , PetersFP , CurversWL , RosmolenWD , et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy2008;40(5):370-9.">Gondrie 2008b</a>; <a href="./references#CD007334-bbs2-0105" title="SharmaVK , KimHJ , DasA , DeanP , DePetrisG , FleischerDE . A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Gastrointestinal Endoscopy2008;40(5):380-7.">Sharma 2008</a>) to reduce the future malignant potential of the residual Barrett's safely. In terms of eradication of Barrett's oesophagus tissue, RFA seems to be able to remove benign Barrett's oesophagus completely without any major complications (<a href="./references#CD007334-bbs2-0104" title="SharmaVK , WangKK , OverholtBF , LightdaleCJ , FennertyMB , DeanPJ , et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointestinal Endoscopy2007;65(2):185-95.">Sharma 2007</a>) but the results of further studies, ideally RCTs, are awaited (<a href="./references#CD007334-bbs2-0096" title="RöschT . BARRx for total Barrett's eradication - the new super weapon?Endoscopy2008;40(5):393-4.">Rösch 2008</a>; <a href="./references#CD007334-bbs2-0106" title="SharmaVK , Jae KimH , DasA , WellsCD , NguyenCC , FleischerDE . Circumferential and focal ablation of Barrett's esophagus containing dysplasia. American Journal of Gastroenterology2009;104(2):310-7.">Sharma 2009</a>; <a href="./references#CD007334-bbs2-0108" title="SinghS , SharmaP . How effective is endoscopic therapy in the treatment of patients with early esophageal cancer?Nature Clinical Practice Gastroenterology &amp; Hepatology2009;6(2):70-1.">Singh 2009</a>). After endotherapy, patients must continue to attend for surveillance endoscopies and of note 13% of the endotherapy group in <a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> failed to attend the follow‐up appointments upon which success may depend. </p> </section> <section id="CD007334-sec-0051"> <h4 class="title">Quality of life</h4> <p>The assessment of QoL in clinical trials does not have a universally accepted definition, although <a href="./references#CD007334-bbs2-0044" title="EfficaceF , BottomleyA , OsobaD , GotayC , FlechtnerH , D'haeseS , et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials - does HRQOL evaluation in prostate cancer research inform clinical decision making?Journal of Clinical Oncology2003;18:3502-11.">Efficace 2003</a> suggested that a number of standard criteria could be employed. Ideally the measures should be multi‐dimensional and self‐reported (<a href="./references#CD007334-bbs2-0025" title="BlazebyJ . Medicinal herbs for esophageal cancer [comment]. Cochrane Database of Systematic Reviews2007. [DOI: 10.1002/14651858.CD004520.pub3]">Blazeby 2007</a>). Both treatment modalities appeared to have a similar impact on QoL one year or more after treatment compared with age‐matched controls and younger patients who had oesophagectomy had a greater impairment in QoL than older patients who had surgery (<a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a>). <a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> made some attempt to look at QoL retrospectively by noting the Eastern Cooperative Oncology Group performance scores (ECOG PS) pre‐treatment and at the end of follow‐up. The proportion of patients with an ECOG PS of one or less 1 (equivalent to being symptomatic but completely ambulatory or being asymptomatic) in the endoscopic therapy/surgical groups was similar before and after treatment. </p> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> explored QoL and fear of cancer recurrence in 81 patients over a follow‐up period of 12 to 60 months after endoscopic or surgical treatment for early Barrett's neoplasia using a non‐randomised cross‐sectional design. There were more eating problems and reflux symptoms in the surgery group but those treated endoscopically were reported to have more fear of recurrence surgery patients (statistically significant). The study investigators commented that strategies to educate and address fear of cancer recurrence may be useful. Future studies would ideally report on QoL as well as survival and incidence of recurrent or new dysplasia and cancer. </p> </section> <section id="CD007334-sec-0052"> <h4 class="title">Cost</h4> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> reported that hospital charges were USD40,079 in the endotherapy group as compared with USD66,060 in the surgical group over a mean follow‐up period of 20 and 48 months, respectively. However, the surgical group was unlikely to generate further costs whereas the endoscopic therapy group would require long‐term surveillance and possibly further treatments. A study by <a href="./references#CD007334-bbs2-0060" title="HurC , NishiokaNS , GazelleGS . Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Digestive Diseases and Sciences2003;48:1273-83.">Hur 2003</a> showed that, for these reasons, PDT‐treated patients would generate higher costs than those undergoing oesophagectomy in the long term. A subsequent detailed cost‐effectiveness analysis was undertaken in <a href="./references#CD007334-bbs2-0100" title="ShaheenNJ , InadomiJM , OverholtBF , ShamraP . What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut2004;53:1736-44.">Shaheen 2004</a> using decision analysis modelling to compare endoscopic surveillance, endoscopic ablation therapies and oesophagectomy in HGD in Barrett's oesophagus. They found endoscopic ablation therapy to be both cheaper and more effective (in terms of discounted quality‐adjusted life years) than oesophagectomy, even when the model was weighted towards oesophagectomy by assuming all surgery was undertaken in high volume centres and all endoscopic ablation patients required costly long‐term endoscopic surveillance post‐treatment. Endoscopic surveillance was the least expensive option but resulted in almost 20% of the patients developing cancer. Oesophagectomy provided the lowest risk of developing cancer but only when yearly rates of progression of HGD to cancer exceeded an unrealistic 30% did it become the most cost‐effective option. <a href="./references#CD007334-bbs2-0115" title="VijR , TriadafilopoulosG , OwensDK , KunzP , SandersGD . Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointestinal Endoscopy2004;60(5):739-56.">Vij 2004</a> used a similar decision analysis model to compare costs of PDT and oesophagectomy and concluded that PDT followed by endoscopic surveillance incurred greater life‐time cost but was more cost‐effective in terms of quality‐adjusted life years. In a hypothetical cohort of male patients with Barrett's oesophagus and HGD, PDT and oesophagectomy or surveillance were examined. Surveillance was the least costly approach, but the least effective. The report concluded that PDT and oesophagectomy were cost‐effective alternatives to surveillance only (<a href="./references#CD007334-bbs2-0036" title="ComayD , BlackhouseG , GoereeR , ArmstrongD , MarshallJK . Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Canadian Journal of Gastroenterology2007;21(4):217-22. [PMID: 17431509]">Comay 2007</a>). This is further supported by a decision analysis model by <a href="./references#CD007334-bbs2-0090" title="PohlH , SonnenbergA , StrobelS , EckardtA , RoschT . Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis. Gastrointestinal Endoscopy2009;70(4):623-31. [PMID: 19394011]">Pohl 2009</a>. This mathematical modelling study concluded that although only limited long‐term outcomes of endotherapies are available, endoscopic therapy for early Barrett's oesophagus adenocarcinoma is more effective and costs less than surgical therapy. </p> <p>A cost‐utility analysis using a decision analysis model based on a hypothetical cohort of 50‐year old patients with a diagnosis of Barrett's oesophagus, endoscopic ablation of HGD in subjects with Barrett's oesophagus was found to be "probably cost effective" in that it was estimated to be less costly and more effective than oesophagectomy or surveillance alone. Ablation of HGD was found to be capable of extending life expectancy by more than three quality‐adjusted life years at an incremental cost of less than USD6000 compared with no intervention. While the costs of different ablation types varied, they seem to be similar in terms of effectiveness. The authors noted that "as further post ablation data become available, the optimal strategy to be implemented will be clarified" (<a href="./references#CD007334-bbs2-0062" title="InadomiJ , SomsoukM , ThomasJ , ShaheenN . A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology2009;136:2101-14.">Inadomi 2009</a>). </p> <p>One UK‐based cost‐utility analysis of RFA or oesophagectomy concluded that a policy of RFA with oesophagectomy for HGD recurrence was a cost‐effective strategy when compared to immediate oesophagectomy (<a href="./references#CD007334-bbs2-0026" title="BogerPC , TurnerD , RoderickP , PatelP . A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. Alimentary Pharmacology &amp; Therapeutics2010;32(11-12):1332-42.">Boger 2010</a>). RFA generated an additional 0.4 quality‐adjusted life years at a cost saving of GBP1902 compared to oesophagectomy. <a href="./references#CD007334-bbs2-0026" title="BogerPC , TurnerD , RoderickP , PatelP . A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. Alimentary Pharmacology &amp; Therapeutics2010;32(11-12):1332-42.">Boger 2010</a> concluded that only with an RFA failure rate (progression or persistence of HGD) of more than 44% or an annual risk of HGD recurrence of more than 15% following ablation would immediate oesophagectomy become the more cost‐effective option in the management of HGD. Similarly, one systematic review of the cost‐effectiveness of PDT in HGD identified three out of four studies where PDT ablation was found to be cost‐effective compared to oesophagectomy or endoscopic monitoring, although reported cost‐effectiveness ratios varied widely between each study (<a href="./references#CD007334-bbs2-0098" title="SanchezA , RezaM , BlascoJA , CallejoD . Effectiveness, safety, and cost-effectiveness of photodynamic therapy in Barrett's esophagus: a systematic review. Diseases of the Esophagus2010;23(8):633-40. [1120-8694]">Sanchez 2010</a>). </p> </section> </section> <section id="CD007334-sec-0053"> <h3 class="title" id="CD007334-sec-0053">Potential biases in the review process</h3> <p>None known.</p> </section> <section id="CD007334-sec-0054"> <h3 class="title" id="CD007334-sec-0054">Agreements and disagreements with other studies or reviews</h3> <p>With the limited data available and lack of published RCTs comparing endoscopic treatment with oesophagectomy, it is impossible to reach firm comparative conclusions. This observation is consistent with that of a systematic review comparing safety and effectiveness of endotherapy compared to oesophagectomy in the treatment of HGD and early cancer (<a href="./references#CD007334-bbs2-0075" title="MenonD , StafinskiT , WuH , LauD , WongC . Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterology2010;10:111.">Menon 2010</a>). Endotherapy was shown to be safer in terms of mortality (0.04% versus 1.2%) although high stricture rates were identified as a significant problem following PDT ablation (18.5% with PDT compared to 5.3% with oesophagectomy). The absence of randomised trial evidence meant that selection and publication bias were significant. In addition, the studies included were predominantly conducted prior to the widespread uptake of RFA. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007334-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/media/CDSR/CD007334/urn:x-wiley:14651858:media:CD007334:CD007334-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007334-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007334.pub5/media/CDSR/CD007334/image_n/nCD007334-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/media/CDSR/CD007334/image_t/tCD007334-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/media/CDSR/CD007334/image_n/nCD007334-FIG-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD007334-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Demographic data</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment modalities investigated</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No. of patients</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ratio endoscopic: surgical therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Male (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean age years</b> </p> <p><b>(/surgery)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Histological type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up time</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined PDT and EMR vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24:64</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 endotherapy group</p> <p>68 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adenocarcinoma T1m / T1sm (stage 1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PDT vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>199</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129:70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> <p>endotherapy group</p> <p>60 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 years</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective from SEER database</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ER, thermal ablation, PDT or a combination vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>742</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99:643</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>endotherapy group</p> <p>68 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All histological types TisN0M0 (stage 0) or T1N0M0 (stage 1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean follow‐up time in SEER database (23.9 (SE 1.8) for endoscopic treatment; 25.3 (SE 0.7) months for surgery </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PDT or EMR vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47:49</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> <p>endotherapy group</p> <p>59 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median follow‐up for 48 patients who were operative survivors after resection of HGD was 56 months (range 1‐250 months). No follow‐up data were given for the endoscopy group </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMR, APC, PDT or a combination vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62:32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73% endotherapy group</p> <p>93%  oesophagectomy group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> <p>endotherapy group</p> <p>64 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD or IMC in Barrett's</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean follow‐up for the endoscopic therapy was a median 20 months' with a range of 6 to 84 months. For the surgery group, the median follow‐up was 48 months with a range of 6 to 88 months </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective single institution</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Endoscopic ablation vs. oesophagectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>159</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80:70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.7</p> <p>endotherapy group</p> <p>63.1 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Barrett's oesophagus patients who had undergone oesophagectomy or endoscopic ablation. Prior to treatment, 70.4% of patients were diagnosed as HGD/IMC or T1sm, but 29.6% of participants were stage T2 or greater). </p> <p>Post‐oesophagectomy pathology was only reported in the participants with HGD or IMC. Disease was limited to the mucosa in 80% (24 of 30 participants). Efficacy was not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No long‐term outcomes reported (not the primary focus of the study)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR + RFA (therapeutic and salvage) vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 in total, 73 reported in detail.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33:40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 (ratio 5.4:1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median age 65 years (range 29 to 86 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrett's oesophagus with early malignant lesions, defined as HGD, IMC and submucosal T1 adenocarcinoma. No further details given in study report, as 1 patient had T1N1 disease, the study may have included patients with more or less advanced disease </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Described as a 10‐year audit but length of follow‐up not clear (very short report)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective data from 2 high‐volume centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ER + APC vs. en bloc transthoracic oesophageal resection with 2‐field lymphadenectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76:38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 endotherapy group</p> <p>97 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median age</p> <p>62.2 endotherapy group</p> <p>62.7 surgery group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Matched cases with respect to age, gender, infiltration depth (pT1m1‐3), differentiation grade (G1/2 vs. 3) and follow‐up period </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1 years endotherapy group</p> <p>3.7 years surgery group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective cross‐sectional review by questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endotherapy vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81:33 (66 endoscopy and 29 surgery responded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83 endotherapy group</p> <p>82 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.1 (SD 8.2) endotherapy group</p> <p>63 (SD 9.5) surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD, early cancer (cancer<br/>limited to the mucosa [T1m] or superficial submucosa [T1sm1]), or both </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 to 60 months after treatment</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endotherapy (various) vs. oesophagectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (40 responded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27:13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 endotherapy group</p> <p>93 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 endotherapy group</p> <p>63 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrett's oesophagus with HGD or IMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear, study examines cases from 1998 to 2007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR vs. oesophagectomy (2/3 transhiatal; 1/3 transthoracic)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (31 had oesophagectomy without CRT; 15 had EMR without CRT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15:31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.8 endotherapy group</p> <p>92.3 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.9 endotherapy group</p> <p>67.1 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Submucosal oesophageal adenocarcinoma (T1b oesophageal adenocarcinomas)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective review of pathology database</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>APC vs. oesophagectomy (vs. surveillance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 (13 having APC or surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5:8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 endotherapy group</p> <p>87.5</p> <p>surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 endotherapy group</p> <p>58 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD and medically unfit or chose not to have oesophagectomy in APC group.</p> <p>Persistent HGD on repeat biopsies done after a mean interval of 2 months in surgery group. </p> <p>Results reported for HGD groups (not adenocarcinoma) only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months APC, up to 60 months oesophagectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Retrospective single institution</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>EMR vs. oesophagectomy (transthoracic en bloc, transhiatal, minimally invasive, or vagus sparing) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40:61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 endotherapy group</p> <p>70 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 endotherapy group</p> <p>68 surgery group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HGD or IMC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 and 5 years</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>APC: argon plasma coagulation; CRT: chemoradiotherapy; EMR: endoscopic mucosal resection; ER: endoscopic resection; HGD: high‐grade dysplasia; IMC: intramucosal cancer; PDT: photodynamic therapy; SD: standard deviation; SE: standard error; SEER: Surveillance, Epidemiology, and End Results. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Demographic data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007334-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Primary outcome: survival</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival in endoscopic treatment group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival in surgical group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significantly different?</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at end of follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92% at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97% at 19 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91% at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91.5% at 5 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median cancer‐free survival</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference between the 2 groups (P = 0.41)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival at 5 and 10 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% at 5 years (disease specific 93%), 64% at 10 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adjusted 4‐year survival</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89% (0 due to oesophageal cancer)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (none due to oesophageal cancer)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Vital status" was reported in <a href="#CD007334-tbl-0001">Table 1</a> of this study, for the aggregated group of all patients, regardless of cancer stage (54% of patients were ≥ stage T2). There were no significant differences (P = 0.60) between the numbers of deceased participants in the oesophagectomy (10%) or ablation (13%) groups. The interval between treatment and death and cause of death were not reported </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival 1, 3 and 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99% at 1 year</p> <p>96% at 3 years</p> <p>89% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97% at 1 year</p> <p>93% at 3 years</p> <p>93% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No differences between the 2 groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported, not the focus of the study (QoL focus)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median overall survival duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No (note: survival rates are for the whole group including those who had CRT in addition to EMR or surgery). In multivariate Cox modelling, age, co‐morbidities sex and oesophagectomy were not associated with survival duration. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear (not the focus of the study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62% at mean 18.5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear, not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall survival at 3 and 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94% at 3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94% at 3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CRT: chemoradiotherapy; EMR: endoscopic mucosal resection; QoL: quality of life.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Primary outcome: survival</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007334-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Secondary outcomes</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Cancer‐free survival</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Treatment failures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Procedure‐related mortality (30 day)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Complications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>QoL</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic treatment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgical treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0003" title="PacificoRJ , WangKK , WongkeesongL , ButtarNS , LutzkeLS . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology2003;1:252-7. ">Pacifico 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% (20/24) remained free of cancer at 12 ± 2 and 19 ± 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All patients remained free of cancer at 12 ± 2 and 19 ± 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent cancer at first follow‐up 17% (4/24 patients). No later recurrence</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stricture: 8%</p> <p>Photo‐</p> <p>sensitivity: 8%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stricture: 16%</p> <p>Anastomotic leak: 8%</p> <p>Wound infection: 8%</p> <p>Dumping syndrome: 5%</p> <p>Empyema (pus in the pleural cavity): 3%</p> <p>Blood transfusion: 3%</p> <p>Atrial fibrillation: 3%</p> <p>Aspiration: 2%</p> <p>Chylothorax (lymphatic effusion in the pleural cavity): 2%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0005" title="PrasadG , WangK , ButtarN , WongkeesongL , KrishnadathK , NicholsF , et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology2007;132:1226-33. ">Prasad 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference between groups but tendency towards lower cancer‐free survival in endoscopic therapy group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HGD eliminated: at 1 year: 88%; at 3 years: 86%</p> <p>HGD detected within 12 months: 26% (33/129) i.e. failed initial therapy and retreated, HGD eradicated in 70% of these. </p> <p>Recurrence of HGD (detected after 12 months free of HGD): 7.8% (10/129)</p> <p>Cancer detected during follow‐up (up to 18 months after PDT): 6.2% (8/129)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No early complications</p> <p>Stricture formation: 27%</p> <p>Photosensitivity: 60%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38% Postoperative morbidity</p> <p>Stricture formation: 12.6%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No QoL data, performance score only given</p> <p>ECOG PS?1 in 73% at end of FU*</p> <p>Proportions unchanged from pre‐therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No QoL data, performance score only given</p> <p>ECOG PS?1 in 94% at end of FU*</p> <p>Proportions unchanged from pre‐therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0001" title="DasA , SinghA , FleischerD , SharmaV . A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology2008;103:1340-5. ">Das 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(Only oesophageal cancer‐specific cause of death considered)</p> <p>56 months (50 to 61 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 months (57 to 67 months) (no significant difference)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0006" title="ReedMF , TolisG , EdilBH , AllanJS , DonahueDM , GaissertHA , et al. Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery2005;79:1110-5. ">Reed 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/42 PDT and 2/5 EMR patients had recurrent HGD/cancer after mean 13.5 months. 1 developed metastatic spread but 0 died during follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/49 patients died from recurrent disease</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (cerebrovascular accident in postoperative period)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anastomotic leaks: 4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0007" title="RosmolenWD , BoerKR , De LeeuwRJR , GamelCJ , VanBH , BergmanJJGH . Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barretts esophagus. Endoscopy2010;42(7):525-31. [0013-726X]">Rosmolen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant bleeding: 3%, perforation: 2%, oesophageal stenosis: 31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptomatic anastomotic leakage: 15 %, pulmonary<br/>problems: 30 %, serious infections: 15 % and vocal cord<br/>paralysis: 15 %. Anastomotic<br/>stenosis in 37% during follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QoL measured (SF‐36, EORTC‐QLQ‐C30, EORTC‐QLQ‐OES18 questionnaires). HADS, WOCS.</p> <p>Endoscopy patients reported more fear of recurrence on the WOCS than surgery patients (P = 0.003). </p> <p>No significant differences were found between the 2 groups on the other outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgery patients had significantly more eating problems (OR 18.3; P &lt; 0.001) and reflux symptoms (OR 3.4; P = 0.05) on the EORTC‐OES18 questionnaire </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0008" title="SchembreD , HuangJ , LinO , CantoneN , LowD . Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy2008;67(4):595-601. ">Schembre 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Residual Barrett's segment in 44%,</p> <p>persistent dysplasia in 13%,</p> <p>progression to cancer in 6%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Residual Barrett's segment in 3%,</p> <p>persistent dysplasia in 3%,</p> <p>no progression to cancer</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%: 1 patient died from diverticulitis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major: 8%</p> <p>Minor: 32%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major: 13%</p> <p>Minor: 66% (significantly different)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007334-bbs2-0012" title="YachimskiP , NishiokaNS , RichardsE , HurC . Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clinical Gastroenterology and Hepatology2008;6(11):1206-11. ">Yachimski 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0002" title="FarrellNO , RaviN , MalikV , LarkinJO , WilsonGF , MuldoonC , et al. Evolving changes in the management of early oesophageal adenocarcinoma. Irish Journal of Medical Science.Conference: 36th Sir Peter Freyer Memorial Lecture and Surgical Symposium Galway Ireland. Conference 2011 Sept 2 to 2011 Sept 32011:S253. [0021-1265]">Farrell 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In patients treated by EMR + RFA, there was 100% disease control; 72% had complete eradication of Barrett's disease, and 1 patient </p> <p>represented with low‐grade dysplasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8% surgical patients relapsed with HGD or cancer and 1 patient with T1N1 disease died of recurrent disease </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear from study report</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear from study report</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% mortality and 32% morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% morbidity from EMR + RFA (statistically significant compared with surgery P=0.001)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0004" title="LeungWD , ChennatJ . Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barretts esophagus. Expert Review of Gastroenterology and Hepatology2011;5(5):575-8. [1747-4124]PechO , BollschweilerE , MannerH , LeersJ , EllC , HolscherAH . Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Annals of Surgery2011;254(1):67-72. [0003-4932]">Pech 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.7% at 4.1 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3.7 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6% (repeat endoscopic treatment was successful in all patients who experienced disease recurrence </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No deaths from tumour‐related disease during follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality at 40 days 2.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minor complication in 17% (bleeding managed by clipping or injection). No major complications (severe bleeding, perforation stenosis) observed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32% major complications. including anastomotic leakage, pneumonia, multiple organ failure following sepsis, cardiac problems </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0009" title="SchembreD , AraiA , LevyS , Farrell-RossM , LowD . Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia. Diseases of the Esophagus2010;23(6):458-64. [1120-8694]">Schembre 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36: no significant differences compared with surgery</p> <p>GIQLI: higher (better) scores among ASA Class 1 and 2 endotherapy patients compared with surgery (not statistically significant) and higher among young endotherapy patients than young surgery patients </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SF‐36: no significant differences other than superior physical functioning in patients 65 years of age and older </p> <p>GIQLI: no significant differences in scores of older patients for surgery and endotherapy or SAS 3 patients. </p> <p>Negative QoL impact appears to be greater for younger patients undergoing surgery.</p> <p>(overall QoL scores: "QOL scores among EG and ET groups were not significantly different than sex age‐matched controls” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0011" title="TianJ , PrasadGA , LutzkeLS , LewisJT , WangKK . Outcomes of T1b esophageal adenocarcinoma patients. Gastrointestinal Endoscopy2011;74(6):1201-6. [0016-5107]">Tian 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In group who had EMR as only therapy, 21.4% had cancer recurrence at 45 months follow‐up (remaining 11 had mean cancer‐free periods of 21 months) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 death at 34 days owing to anastomotic leak (with 'do not resuscitate' order)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0010" title="ThomasT , RichardsCJ , deCaesteckerJS , RobinsonRJ . High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Alimentary Pharmacology and Therapeutics2005;21(6):747-55. [PMID: 15771761]">Thomas 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/5 went on to develop metastatic adenocarcinoma<br/>at 9 and 12 months follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/8 patients developed recurrent adenocarcinoma at 22 and 60 months after surgery, 1 of whom died </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative morbidity in 4 patients (pneumonia, adult respiratory distress syndrome, pneumothorax) 2/8 developed postoperative strictures at 3 to 6 months' postsurgery requiring ongoing dilation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007334-bbs2-0013" title="ZehetnerJ , DeMeesterSR , HagenJA , AyaziS , AugustinF , LiphamJC , et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery2011;141(1):39-47. [0022-5223]">Zehetner 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3 years;</p> <p>100% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100% at 3 years;</p> <p>88% at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% had new or metachronous cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39% had complications including long‐term complications of anastomotic strictures, ventral hernias, reflux, postprandial dumping or diarrhoea </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>*ECOG PS 0 = fully active, able to carry on all pre‐disease performance without restriction.</p> <p>ECOG PS 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. </p> <p>ASA: American Society of Anesthesia; EMR: endoscopic mucosal resection; EORTC‐QLQ: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; FU: fluorouracil; GIQLI: Gastrointestinal Quality of Life Index; HADS: Hospital Anxiety and Depression Scale; OR: odds ratio; PDT: photodynamic therapy; QoL: quality of life; RFA: radiofrequency ablation; SF‐36: 36‐item Short Form; WOCS: Worry Of Cancer Scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007334.pub5/full#CD007334-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007334.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007334-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007334-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD007334-note-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD007334-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007334-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007334\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007334\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007334\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007334\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007334\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PrHmaMrX&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007334.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007334.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007334.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007334.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007334.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725610850"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007334.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725610854"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007334.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e7f75be3bf466',t:'MTc0MDcyNTYxMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 